mesalamine has been researched along with sulfasalazine in 502 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 126 (25.10) | 18.7374 |
| 1990's | 164 (32.67) | 18.2507 |
| 2000's | 107 (21.31) | 29.6817 |
| 2010's | 84 (16.73) | 24.3611 |
| 2020's | 21 (4.18) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JP; McGarraugh, GV; Onderdonk, AB; Parkinson, TM; Wingard, RE | 1 |
| Clerici, C; Garzon-Aburbeh, A; Gentili, G; Marinozzi, M; Morelli, A; Natalini, B; Pellicciari, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Dhaneshwar, SS; Kadam, SS; Kandpal, M; Rathi, B; Vadnerkar, G | 1 |
| Bhatt, L; Dhaneshwar, SS; Gairola, N; Kadam, SS; Kandpal, M; Vadnerkar, G | 1 |
| Bhatt, L; Dhaneshwar, SS; Gairola, N; Kandpal, M; Vadnerkar, G | 1 |
| Collins, MT; Shin, SJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chail, M; Dhaneshwar, SS; Naqvi, S; Patil, M; Vadnerkar, G | 1 |
| Bhatt, L; Dhaneshwar, SS; Gairola, N; Kadam, SS; Kandpal, M; Rathi, B; Vadnerkar, G | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alt, J; Ferraris, DV; Hin, N; Rojas, C; Sattler, R; Shukla, K; Slusher, BS; Thomas, AG; Tsukamoto, T | 1 |
| Li, F; Wang, L; Wu, G; Zhao, Z; Zheng, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banskota, S; Jang, H; Jeong, BS; Kang, HE; Karmacharya, U; Kim, DG; Kim, JA; Nam, TG; Park, SW | 1 |
| Banskota, S; Bist, G; Gurung, P; Kadayat, TM; Kim, JA; Lee, ES; Shrestha, A; Thapa Magar, TB | 1 |
| Banskota, S; Bist, G; Gurung, P; Kadayat, TM; Kim, JA; Lee, ES; Magar, TBT; Shrestha, A | 1 |
| Banskota, S; Chaudhary, CL; Gurung, P; Jeong, BS; Jin, YJ; Kang, HE; Kim, JA; Lee, SY; Nam, TG; Park, SW | 1 |
| Awasthi, BP; Chaudhary, P; Jeong, BS; Karmacharya, U; Kim, JA; Kim, YE; Lee, IH; Nam, TG; Regmi, SC | 1 |
| Drab, EA; Linder, JS; Rubin, DB; Sabesin, SM; Sharon, P; Weidman, SW | 1 |
| Giaffer, MH; Holdsworth, CD; O'Brien, CJ | 1 |
| Gaginella, TS; Levin, S; Tamai, H | 1 |
| Eigler, FW; Goebell, H | 1 |
| Fischbach, W | 1 |
| Gaginella, TS; Walsh, RE | 1 |
| Duncan, A; Nakshabendi, IM; Russell, RI | 1 |
| Goldstein, F | 1 |
| Bennett, A; Evans, BK; Mills, CM; Rhodes, J; Swift, GL; Tavares, IA | 1 |
| Boswell, DJ; Greenfield, SM; Punchard, NA; Thompson, RP | 1 |
| Tremaine, WJ | 1 |
| Tolia, V | 1 |
| Belluzzi, A; Daneshmend, TK; Everitt, SJ; Hawkey, CJ; Hawthorne, AB; Holmes, GK; Malkinson, C; Shaheen, MZ; Willars, JE | 1 |
| Karmeli, F; Rachmilewitz, D; Schwartz, LW; Simon, PL | 1 |
| Allgayer, H | 1 |
| Maier, KP | 1 |
| Goldman, DH; Lawson, GM; Perrault, J; Sandborn, WJ | 1 |
| Crouch, R; Davis, AE; Patterson, F | 1 |
| Baron, JH; Barrison, IG; Giaffer, MH; Hoare, AM; Holdsworth, CD; Lennard-Jones, JE; Manjunatha, S; McIntyre, PB; Polson, RJ; Rodrigues, CA | 1 |
| Binder, V; Davidsen, M; Langholz, E; Munkholm, P | 1 |
| Butt, JH | 1 |
| Rijk, MC; van Schaik, A; van Tongeren, JH | 3 |
| Selve, N | 1 |
| Hawkey, CJ; Hawthorne, AB; Mahida, YR | 1 |
| Eliakim, R; Karmeli, F; Ligumsky, M; Rachmilewitz, D; Simon, P | 1 |
| Bukhave, K; Lauritsen, K; Laursen, LS; Rask-Madsen, J | 1 |
| Adler, M; Bourgeois, N; Devis, G; Duville, L; Hautekeete, ML; Klöppel, G; Potvin, P; Reynaert, H | 1 |
| Michalowski, AS | 1 |
| Carlin, G; Djursäter, R; Smedegård, G | 1 |
| Batts, KP; Carpenter, HA; Czaja, AJ; Tremaine, WJ | 1 |
| Hüppe, D; Krieg, M; Kuntz, HD; May, B; Schwegler, U; Thau, I; Tromm, A | 1 |
| Barbara, L; Belluzzi, A; Brignola, C; Campieri, M; Gionchetti, P; Guarnieri, C; Iannone, P; Miglioli, M | 2 |
| Kleemeyer, K; Peskar, BA; Peskar, BM; Wittenberg, HR | 1 |
| Bjarnason, I; Hayllar, J | 1 |
| Fitzgerald, JM; Marsh, TD | 1 |
| Alstead, EM; Farthing, MJ; Wilson, AG | 1 |
| Kovács, A | 1 |
| Aparicio-Pagés, MN; Crama-Bohbouth, GE; Edelbroek, PM; Hafkenscheid, JC; Lamers, CB; Peña, AS; Verspaget, HW; Verver, S; Weterman, IT | 1 |
| Fabel, H; Hamm, H; Welte, T | 1 |
| Rothbart, D | 1 |
| Greenfield, SM; Punchard, NA; Thompson, RP | 1 |
| Hartmann, F; Plauth, M | 1 |
| Goebell, H; Kölbel, C | 1 |
| Ditschuneit, H; Horn, H; Preclik, G; Stange, EF | 1 |
| Kruis, W | 1 |
| Feurle, GE | 1 |
| Fox, CC; Lichtenstein, LM; Moore, WC | 1 |
| Capell, HA; Madhok, R; Smith, J; Sturrock, RD; Watson, J; Wijelath, E | 1 |
| Sutherland, LR | 2 |
| Eliakim, R; Ligumsky, M; Rachmilewitz, D; Wengrower, D | 1 |
| Ahnfelt-Rønne, I; Binder, V; Christensen, A; Langholz, E; Nielsen, OH; Riis, P | 1 |
| d'Albasio, G; Ghetti, A; Milla, M; Morettini, A; Nucci, A; Pacini, F; Trallori, G | 1 |
| Biddle, WL; Miner, PB | 1 |
| Eliakim, R; Karmeli, F; Rachmilewitz, D | 1 |
| Hanauer, SB | 4 |
| Brimblecombe, R | 1 |
| Grisham, MB | 1 |
| Williams, JG | 1 |
| Bostwick, JS; Decktor, DL; Fitzpatrick, LR; Pendleton, RG; Renzetti, M | 1 |
| Chapman, ML; Gray, CE; Kornbluth, AA; Kramer, A; Present, DH; Sachar, DB; Salomon, P; Subramani, K | 1 |
| Bruckstein, AH | 1 |
| Aparicio-Pagés, MN; Crama-Bohbouth, GE; Hafkenscheid, JC; Lamers, HW; Peña, AS; Verspaget, HW; Weterman, IT | 1 |
| Cho, CH; Garg, GP; Ogle, CW | 1 |
| Cigala, O; Della Valle, M; Marasco, A; Pancallo, MT | 1 |
| Bresci, G; Carrai, M; Gambardella, L; Venturini, G | 1 |
| Fujiwara, M; Mitsui, K; Yamamoto, I | 1 |
| Hillier, K; Pacheco, S; Smith, CL | 1 |
| Bertovich, MJ; MacDermott, RP; Nash, GS; Peters, M; Schloemann, SR; Stenson, WF | 1 |
| Granger, DN; Grisham, MB; von Ritter, C | 1 |
| Rachmilewitz, D | 1 |
| Ginsberg, AL | 1 |
| Klotz, U; Massoud, N; Tolia, V | 1 |
| Friedman, LS | 1 |
| Delaere, KP; Meuleman, EJ; Strijbos, WE | 1 |
| Ahnfelt, NO; Allgayer, H; Frank-Holmberg, K; Klotz, U; Kruis, W; Paumgartner, G; Söderberg, HN | 1 |
| Van Rosendaal, GM | 1 |
| Christensen, LA; Hansen, SH; Kjaergaard, N; Lauritsen, JG; Rasmussen, SN | 1 |
| Lauritsen, K | 1 |
| Edenius, C; Lindgren, JA; Sjöquist, B; Smedegård, G; Tornhamre, S | 1 |
| Aitken, RJ; Ferguson, A; Wu, FC | 1 |
| Greenwell, BE | 1 |
| Hallett, MB; Williams, JG | 1 |
| Rijk, MC; van Hogezand, RA; van Schaik, A; van Tongeren, JH | 1 |
| Dölle, W; Hartmann, F | 1 |
| Chungi, VS; Dittert, LW; Shargel, L | 1 |
| Rutgeerts, P | 2 |
| Barden, L; Lipson, A; Pert, P; Walker-Smith, JA | 1 |
| Donowitz, M | 1 |
| van Hees, PA; van Hogezand, RA; van Rossum, JM; van Tongeren, JH; Zwanenburg, B | 1 |
| Bode, JC; Frühmorgen, P; Heller, T; Klotz, U; Maier, K; von Gaisberg, U | 1 |
| Becker, R; Kolassa, N; Wiener, H | 1 |
| Banatwala, N | 1 |
| Capell, HA; Hunter, JA; Pullar, T | 1 |
| Antonioli, DA; Barber, GB; Lee, DE; Peppercorn, MA | 1 |
| Bazzocchi, G; Brignola, C; Campieri, M; Del Soldato, P; Gionchetti, P; Lanfranchi, GA; Tamba, M | 1 |
| Anttila, PM; Pentikäinen, PJ; Välimäki, M | 1 |
| Gibson, PR; Jewell, DP | 1 |
| Boughton-Smith, NK; Hawkey, CJ; Whittle, BJ | 1 |
| Lawson, M; Nance, S; Radcliffe, B; Roediger, W; Schapel, G | 1 |
| Allgayer, H; Kruis, W; Paumgartner, G; Sonnenbichler, J | 1 |
| Friedman, G | 1 |
| Gustavsson, S; Ryde, M | 1 |
| Donald, IP; Wilkinson, SP | 1 |
| Feurle, GE; Helmstädter, V | 1 |
| Kane, MG; MacDermott, RP; Niederlehner, A; Shanahan, F; Stenson, WF; Targan, S | 1 |
| Astbury, C; Bird, HA; Hill, J; Le Gallez, P; Neumann, VC; Taggart, AJ | 1 |
| Binder, V; Bondesen, S; Danø, P; Hansen, SH; Jensen, PH; Krasilnikoff, PA; Lassen, LB; Nielsen, OH; Rasmussen, SN; Schou, JB | 1 |
| Dreyling, KW; Goebell, H; May, B; Peskar, BA; Peskar, BM | 1 |
| Bender, SW; Kirchmann, H; Posselt, HG | 1 |
| Cooper, BT | 1 |
| Astbury, C; Dixon, JS; Hill, J; Le Gallez, P; Neumann, VC; Taggart, AJ | 1 |
| Bondesen, S; Hansen, SH; Hvidberg, EF; Jacobsen, O; Rasmussen, SN; Tage-Jensen, U | 1 |
| Barnett, KC | 1 |
| Gerok, W; Schölmerich, J | 1 |
| Imamura, S; Miyachi, Y; Niwa, Y; Yoshioka, A | 1 |
| Ang, SB; Lee, EJ | 1 |
| Craven, PA; DeRubertis, FR; Pfanstiel, J; Saito, R | 1 |
| Malchow, H | 1 |
| Calabrese, A; Cappello, M; Cipolla, C; Cottone, M; Gatto, G; Oliva, L; Orlando, A; Puleo, A | 1 |
| Cann, PA; Holdsworth, CD; Rao, SS | 1 |
| van Hees, PA | 1 |
| Asakura, H; Miura, S; Nagata, H; Oshio, C; Suematsu, M; Suzuki, M; Tsuchiya, M; Watanabe, M | 1 |
| Beker, JA | 1 |
| Breiling, J; Franke, M; Gabbert, H; Goerg, KJ; Meyer zum Büschenfelde, KH; Wanitschke, R | 1 |
| Abramson, J; Farquhar, S; Goldstein, F; Thornton, JJ | 1 |
| Neal, TM; Vissers, MC; Winterbourn, CC | 1 |
| Sullivan, SN | 1 |
| Terpstra, JJ | 1 |
| Dreyling, KW; Hoppe, U; Peskar, BA; Peskar, BM; Schaarschmidt, K | 1 |
| Cho, CH; Ogle, CW; Sevilla, EL | 1 |
| Goodman, MJ; Lecarpentier, J; Mandal, BK; Mani, V; Riley, SA; Turnberg, LA | 1 |
| Anttila, VJ; Elomaa, I; Seppälä, K; Turunen, U | 1 |
| Ahnfelt-Rønne, I; Bukhave, K; Elmgreen, J; Nielsen, OH | 1 |
| Aruoma, OI; Butler, J; Halliwell, B; Hoey, BM; Wasil, M | 1 |
| Dull, BJ; Goldman, P; Salata, K | 1 |
| Dreyling, KW; Goebell, H; May, B; Peskar, BM; Schaarschmidt, K | 1 |
| Martin, F | 1 |
| Ambrosius Christensen, L; Bondesen, S; Hansen, SH; Hvidberg, EF; Rasmussen, SN | 1 |
| Greenberg, GR; Habal, FM | 1 |
| Gendre, JP | 2 |
| Batzer, FR; Chatzinoff, M; Corson, SL; Friedman, LS; Guarino, JM | 1 |
| Grisham, MB; Kvietys, PR; Manci, EA; Smith, SM | 1 |
| Dutt, S; Goodman, MJ; Herd, ME; Mani, V; Riley, SA; Turnberg, LA | 2 |
| Dekker, W; Mulder, CJ; Terpstra, IJ; Tytgat, GN | 1 |
| Beninati, L; Buonato, CB; Nielsen, ST | 1 |
| Andersen, LP; Andreasen, JJ; Hartzen, SH | 1 |
| Bacon, PA; Farr, M; Salmon, M; Symmons, DP | 1 |
| Comer, SS; Jasin, HE | 1 |
| Grindulis, KA; Sheldon, P; Webb, C | 1 |
| Riley, SA | 1 |
| Blok, P; Dekker, W; Mulder, CJ; Schrijver, M; Tytgat, GN; van der Heide, H; Weterman, IT | 1 |
| Peppercorn, MA | 2 |
| Daiss, W; Dölle, W | 1 |
| Fardy, JM; Lloyd, DA; Reynolds, RP | 1 |
| Peskar, BM | 1 |
| Goebell, H | 1 |
| Gerritse, R; Poen, H; Scholten, P; te Velde, ER; van Hattum, J; Zelissen, PM | 1 |
| Axon, AT; Burke, DA; Manning, AP; Williamson, JM | 1 |
| Elmgreen, J; Nielsen, OH; Verspaget, HW | 1 |
| Baron, JH; Barrison, IG; Lennard-Jones, JE; McIntyre, PB; Rodrigues, CA; Thornton, PC; Walker, JG | 1 |
| Hoult, JR; Page, H | 1 |
| Bartholomew, TC; Jewell, DP; Rhodes, JM | 1 |
| Fischer, C; Klotz, U; Maier, K | 1 |
| Chastenay, BF; Holdstock, G; Krawitt, EL | 2 |
| Lobos, E; Stenson, WF | 2 |
| Fischer, C; Heinkel, K; Klotz, U; Maier, K | 1 |
| Goldman, P | 1 |
| Dew, MJ; Evans, BK; Harries, AD; Hughes, P; Rhodes, J; Williams, G | 1 |
| Hawkey, CJ; Lo Casto, M | 1 |
| Carethers, ME; Schwender, CF; Sircar, JC | 1 |
| Azad Khan, AK; Nurazzaman, M; Truelove, SC | 1 |
| Dew, MJ; Evans, BK; Evans, N; Harries, AD; Rhodes, J | 1 |
| Aarons, L; Houston, JB; Shaw, PN; Sivner, AL | 1 |
| Dew, MJ; Evans, BK; Harries, AD; Rhodes, J | 1 |
| Das, KM | 1 |
| Fischer, C; Klotz, U; Maier, K; Stumpf, E; von Gaisberg, U | 1 |
| Bazzocchi, G; Brignola, C; Calari, MT; Campieri, M; Lanfranchi, GA; Minguzzi, MR | 1 |
| Dew, MJ; Ebden, P; Evans, BK; Kidwai, NS; Lee, G; Rhodes, J | 1 |
| Lennard-Jones, JE; McIntyre, PB | 1 |
| Cann, PA; Holdsworth, CD | 1 |
| Berrisford, MH; Kershaw, A; Shaffer, JL | 1 |
| Andersen, JO; Hansen, SH; Hvidberg, EF; Jensen, BH; Nørby Rasmussen, S; Poulsen, SS; Skov Olsen, P | 1 |
| Diener, U; Fischer, C; Klotz, U; Maier, K; Tuczek, HV | 1 |
| Lennard-Jones, JE | 1 |
| Pell, P; Sheldon, P | 1 |
| Ghosh, L; Pooley, N; Sharon, P | 1 |
| Augustin, AJ; Lutz, J | 1 |
| Szumlanski, CL; Weinshilboum, RM | 1 |
| Sandborn, WJ; Tremaine, WJ; Zins, BJ | 1 |
| Clearfield, HR; Hirschfeld, S | 1 |
| Loizeau, E | 1 |
| Varela, E | 1 |
| Damiani, VC; Fontana, M; Grassi, M; Raffa, S | 1 |
| Almawi, W; Fabry, S; Keresztes, S; Lipman, M; Moscovitch-Lopatin, M; Peppercorn, MA; Stevens, C; Strom, TB | 1 |
| Schölmerich, J | 2 |
| Arcanà, F; Basso, L; Buffatti, P; Di Bella, F; Doldi, A; Forcheri, V; Gaetini, R; Interisano, A; Pera, A; Pescatori, M | 1 |
| Debongnie, JC; Dekoninck, X | 1 |
| Stark, ME; Tremaine, WJ | 1 |
| Carpani de Kaski, M; Hodgson, HJ | 1 |
| Koop, I | 1 |
| Järvinen, HJ; Turunen, U | 1 |
| Andreoli, A; Levenstein, S; Prantera, C; Spinella, S | 1 |
| Vargas, JH | 1 |
| Ament, ME; Vargas, JH | 1 |
| Kimura, T; Kurosaki, Y; Nakayama, T; Sasaki, K; Yamaguchi, T | 1 |
| Fasoli, R; Jewell, DP | 1 |
| Greenberger, NJ; Miner, PB | 1 |
| Jewell, DP; Travis, SP | 1 |
| Greenberg, GR; Hemphill, D; Steinhart, AH | 1 |
| Aburbeh, AG; Boschetti, E; Clerici, C; Gentili, G; Morelli, A; Natalini, B; Pellicciari, R; Santucci, C | 1 |
| Braegger, CP; MacDonald, TT; Murch, SH; Savage, MO; Torresani, T; Walker-Smith, JA | 1 |
| May, GR; Shaffer, EA; Sutherland, LR | 1 |
| Halter, F; Schmassmann, A | 1 |
| Fukushima, R; Kashima, K; Kitano, A; Nakagawa, M; Nakamura, S; Obayashi, M; Okabe, H; Tabata, A; Tomobuchi, M; Yasuda, K | 1 |
| Scheppach, W | 1 |
| Janowitz, HD; Kornbluth, AA; Mitty, R; Sacks, HS; Salomon, P | 1 |
| Aiso, S; Hayashi, A; Hibi, T; Hosoda, Y; Iwao, Y; Kanai, T; Ogata, H; Ohara, M; Takaishi, H; Watanabe, M | 1 |
| Ahnfelt-Rønne, I; Berild, D; Bouchelouche, PN; Nielsen, OH | 1 |
| Abildgaard, K; Christensen, LA; Fallingborg, J; Hansen, SH; Jacobsen, BA; Rasmussen, HH; Rasmussen, SN | 1 |
| Greenfield, SM; Punchard, NA; Teare, JP; Thompson, RP | 1 |
| Bird, HA | 1 |
| Fukushima, T; Hiwatashi, N; Inoue, M; Kitano, A; Kobayashi, K; Munakata, A; Muto, T; Shimoyama, T; Tsuchiya, S; Yoshida, Y | 1 |
| Munakata, A; Nakajima, H; Yoshida, Y | 1 |
| Baumeister, B; Kosché, E; Schmidt, C; Vetter, H | 1 |
| Ardizzone, S; Bianchi Porro, G; Desideri, S; Molteni, P; Petrillo, M | 1 |
| Sachar, DB | 1 |
| Aparicio, J; Carnicer, F; Girona, E; Gmez, A | 1 |
| Cohen, H; Dooley, C; Kam, L; Orchard, J; Rubin, P | 1 |
| Bird, H; Gardiner, P; Hopkins, R; McEvoy, F; Taggart, A | 1 |
| Davis, P; Grancher, K; Hyams, JS; Justinich, CJ; Lerer, T; Markowitz, J | 1 |
| Mitchell, D; Wareing, M | 1 |
| Grieshaber, M; Grotz, W; Kreisel, W; Wolf, LM | 1 |
| Da Cas, R; Loizzo, A; Tebano, MT; Traversa, G | 1 |
| Campbell, BJ; Dwarakanath, AD; Morris, AI; Rhodes, JM; Stevenson, A; Stretch, GL; Yaqoob, M | 1 |
| Abdo, KM; Hart, RW; Iatropoulos, MJ; Kari, FW; Williams, GM | 1 |
| Aboufadel, A; Hermier, M; Lachaux, A; Le Gall, C; Loras-Duclaux, I | 1 |
| Bianchi, LA; Dreyer, NA; Field, LG; Sutherland, LR; Szneke, P; Walker, AM | 1 |
| Haga, Y; Munakata, A | 1 |
| Kataoka, M; Kawasaki, M; Kimura, I; Nagahama, S; Sato, M | 1 |
| Rückert, Y | 1 |
| Khatchatourian, M; Seaton, TL | 1 |
| Clark, DA; Liu, X; Mannick, EE; Miller, MJ; Sandoval, M | 1 |
| Ardizzone, S; Bianchi Porro, G; Bollani, S; Molteni, P | 1 |
| Bondesen, S | 1 |
| Adler, G; Liptay, S; Schmid, RM; Wahl, C | 1 |
| Cuquerella, J; Ferrer, L; Medina, E; Ortí, E; Pamos, S; Rivera, P; Salvador, I; Tomé, A | 1 |
| Hirose, M; Kitauchi, S; Kuroda, R; Nishi, S; Nishioka, S; Ohata, H; Sakaguchi, A | 1 |
| Ardizzone, S; Bianchi Porro, G | 1 |
| Sarigol, S; Wyllie, R | 1 |
| Steinberg, H | 1 |
| Ben Osman, A; Fenniche, S; Haouet, S; Mokni, M | 1 |
| Piccoli, DA; Sentongo, TA | 1 |
| Kataoka, M; Kimura, I; Kokuba, Y; Kumamoto, T; Matsuda, A | 1 |
| Kataoka, M; Kawasaki, M; Kimura, I; Kokuba, Y; Matsuda, A; Nagahama, S | 1 |
| Kataoka, M; Kawasaki, M; Kimura, I; Kokurba, Y; Matsuda, A | 1 |
| Feagan, BG | 1 |
| Ardizzone, S; Bianchi Porro, G; Bollani, S; Cerutti, R; Imbesi, V; Petrillo, M | 1 |
| Gendler, SJ; Hirsch, RE; Leighton, JA; Morrow, JD; Ritland, SR; Weaver, AL | 1 |
| Preobrazhenskiĭ, VN | 1 |
| Hashimoto, M; Hayami, Y; Hoshihara, Y; Hoshino, J; Ishikawa, S; Sakurazawa, T; Sugawara, K; Tanaka, T; Yamamoto, N; Yamamoto, T | 1 |
| Amin, MA; Campbell, PL; Harlow, LA; Koch, AE; Tokuhira, M; Volin, MV; Woods, JM | 1 |
| Appelman, HD; Barnett, JL; Kim, B; Kleer, CG | 1 |
| Akiya, T; Kon, Y; Motegi, K; Nagasako, K; Nogawa, H; Sawada, T | 1 |
| Aihara, H; Hiwatashi, N | 1 |
| Asakura, H; Sugimura, K | 1 |
| Fujinuma, S; Nakajima, S; Sakai, K; Sakai, Y | 1 |
| Hayashi, N; Honma, N; Iizuka, B; Yamagishi, N | 1 |
| Bamba, T; Nishiyama, Y | 1 |
| Ida, A; Koyama, K | 1 |
| Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
| Ardizzone, S; Bianchi Porro, G; Maconi, G; Parente, F | 1 |
| Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P | 1 |
| Adler, G; Bachem, M; Debatin, KM; Häcker, G; Liptay, S; Schmid, RM | 1 |
| Blackburn, WD; Minghetti, PP | 1 |
| Dekker-Saeys, BJ; Dijkmans, BA; Tytgat, GN | 1 |
| Jung, YJ; Kim, YM; Lee, JS | 1 |
| Duncan, HD; Green, JR; Pearce, CB; Timmis, L | 1 |
| Achkar, JP; Hanauer, SB | 1 |
| Gálvez, J; Garrido, M; Merlos, M; Torres, MI; Zarzuelo, A | 1 |
| Avar, S; Bielecki, JW; Joss, R | 1 |
| Hanauer, SB; Stein, RB | 1 |
| Liang, E; Proudfoot, J; Yazdanian, M | 1 |
| Berg, KJ; Birketvedt, GS; Fausa, O; Florholmen, J | 1 |
| MacDermott, RP | 1 |
| Bdioui, F; Braham, A; Safer, L; Saffar, H; Younes, R; Zili, J | 1 |
| Rutgeerts, PJ | 1 |
| Katz, JA; Pore, G | 1 |
| Harada, K; Inoue, T; Nagakura, N; Oketani, K | 1 |
| Alexander, JS; Grisham, MB; Itoh, M; Joh, T; Jordan, P; Manas, K; Oshima, T; Pavlick, K | 1 |
| Funakoshi, S; Hibi, T; Inoue, N; Ishii, H; Iwao, Y; Naganuma, M; Nakamura, Y; Ogata, H; Yamamoto, S | 1 |
| Deitch, EA; Haskó, G; Németh, ZH; Szabó, C | 1 |
| Gómez-Muñoz, A; O'Brien, L; Salh, B; Steinbrecher, UP | 1 |
| Bellanger, J; Cacoub, P; Godeau, P; Hoang, C; Piette, JC; Sbaï, A; Toan, SV | 1 |
| Franklin, CL; Lipsky, JJ; Loftus, EV; Lowry, PW; Mays, DC; Sandborn, WJ; Szumlanski, CL; Tremaine, WJ; Weaver, AL; Weinshilboum, RM | 1 |
| Ehrsson, H; Eksborg, S; Finkel, Y; Hedin, A; Hildebrand, H; Lidehäll, AK | 1 |
| Chawla, A; Daum, F; Iofel, E; Markowitz, J | 1 |
| Crispino, P; Di Paolo, MC; Iacopini, F; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M; Spera, G | 1 |
| Arakawa, T; Asai, Y; Matsumoto, T; Nabeshima, T; Tokui, K | 1 |
| Gibson, JA; Green, JR; Kerr, GD; Mansfield, JC; Thornton, PC | 1 |
| Cann, PA; Giaffer, MH; Holdsworth, CD; Mansfield, JC; McKenna, D; Thornton, PC | 1 |
| Desager, JP; Dewit, O; Horsmans, Y; Vanheuverzwyn, R | 1 |
| Cézard, JP; Faure, C; Hugot, JP; Le Large-Guiheneuf, C; Mougenot, JF; Munck, A; Navarro, J | 1 |
| Harmsen, WS; Loftus, EV; O'Kane, D; Ricart, E; Sandborn, WJ; Taylor, WR; Tremaine, WJ; Weinshilboum, RM; Zinsmeister, AR | 1 |
| Campbell, PL; Connors, MA; Koch, AE; Volin, MV; Woodruff, DC | 1 |
| Langman, MJ; Ransford, RA | 1 |
| Travis, SP | 1 |
| Brandt, J; Dijkmans, B; Dougados, M; Khan, M; Maksymowych, W; van der Linden, S | 1 |
| Schroeder, KW | 1 |
| B Sartor, R; Böcker, U; Herweck, F; Holt, L; Jobin, C; Nebe, T; Panja, A; Rossol, S; Singer, MV | 1 |
| Beck, P; Makiyama, K; May, G; Roth, D; Sutherland, L | 1 |
| Nagy, F | 1 |
| Rumiantsev, VG; Shchigoleva, NE | 1 |
| Cummings, JH; Edmond, LM; Hopkins, MJ; Magee, EA | 1 |
| Rogozina, VA; Rumiantsev, VG | 1 |
| Flisiak, R; Prokopowicz, D; Wiercińska-Drapało, A | 1 |
| Mansfield, JC | 1 |
| Löfberg, R | 1 |
| Biancone, L; De Nigris, F; Fantini, M; Fina, D; Geremia, A; Pallone, F; Tosti, C | 1 |
| Hino, B; Iida, M; Itoh, Y; Joh, Y; Makino, K; Oishi, R; Teshima, D; Yano, T | 1 |
| Lewis, JD | 1 |
| Feagan, BG; Sandborn, WJ | 2 |
| MacDonald, JK; Sutherland, L | 3 |
| Arakawa, T; Fujiwara, Y; Hato, F; Higuchi, K; Kitagawa, S; Matsumoto, T; Oshitani, N; Watanabe, K | 1 |
| Logan, RF; van Staa, TP | 1 |
| D'Haens, G; van Bodegraven, AA | 1 |
| Forbes, A; Kamm, M; Price, A; Rumbles, S; Rutter, M; Saunders, B; Schofield, G; Talbot, I; Wilkinson, K; Williams, C | 1 |
| Chu, XQ; Jia, LM; Shi, XH; Wang, FM; Zheng, JJ | 1 |
| Cwalina, B; Dzierzewicz, Z; Szczerba, J; Weglarz, L; Wiśniowska, B | 1 |
| Baker, DE; Kane, S | 1 |
| Hanauer, SB; Lim, WC | 1 |
| Begue, B; Cerf-Bensussan, N; Doering, J; Goulet, O; Lentze, MJ; Rieux-Laucat, F; Ruemmele, FM; Schmitz, J | 1 |
| Akobeng, AK; Gardener, E | 1 |
| Chang, EB; Hanauer, SB; Kles, KA; Musch, MW; Turner, JR; Vavricka, SR | 1 |
| Iida, M; Jo, Y; Matsumoto, T | 1 |
| Joshi, R; Kumar, S; Mukherjee, T; Unnikrishnan, M | 1 |
| Choi, EJ; Choi, EY; Choi, SC; Han, WC; Jun, CD; Kim, SW; Lee, HJ; Lee, JG; Lee, MH; Oh, HM; Park, KI; Seo, GS; Yun, KJ | 1 |
| Bauchmuller, K; Bernt, C; Beuers, U; Fickert, P; Fuchsbichler, A; Rust, C; Vennegeerts, T | 1 |
| Choi, B; Jung, Y; Kim, H; Kim, HH; Kim, Y; Kong, H; Yang, Y | 1 |
| Bergman, R; Parkes, M | 1 |
| Sandborn, WJ | 1 |
| Busquets-Pérez, N; Montala, N; Narváez, J; Nolla, JM; Valverde, J | 1 |
| Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R | 1 |
| Burkhart, CG | 1 |
| Cohen, HD; Das, KM | 1 |
| Desreumaux, P; Ghosh, S | 1 |
| Ardizzone, S; Bianchi Porro, G; Iemoli, E; Piconi, S; Raimond, F | 1 |
| Mulder, CJ; van Bodegraven, AA | 1 |
| Andoh, A; Arai, H; Fujiyama, Y; Hanai, H; Hiraishi, H; Hirayama, K; Iida, T; Iwaoka, Y; Kanke, K; Koide, Y; Maruyama, Y; Mitsuyama, K; Nagata, T; Sata, M; Takeuchi, K; Tsujikawa, T; Uchijima, M; Watanabe, F; Yamada, M; Yoshii, S | 1 |
| Neĭman, KP; Rumiantsev, VG | 1 |
| Blumentals, WA; Rubin, DT; Steinbuch, M; Terdiman, JP; Ullman, TA | 1 |
| Binder, V; Jess, T; Langholz, E; Loftus, EV; Munkholm, P; Sandborn, WJ; Scott Harmsen, W; Tremaine, WJ; Velayos, FS; Winther, KV; Zinsmeister, AR | 1 |
| Milanowski, J; Radwan, P; Radwan-Kwiatek, K; łupina, T | 1 |
| Munck, LK; Nielsen, OH | 1 |
| Christensen, LA; Nørgård, B; Pedersen, L; Sørensen, HT | 1 |
| Aslangul, E; Gadhoum, H; Le Jeunne, C; Perrot, S; Romnicianu, S; Szwebel, T | 1 |
| Assem, ES; Pearce, FL; Peh, KH; Wan, BC | 1 |
| Achkar, JP | 1 |
| Bernstein, CN; Moffatt, DC | 1 |
| Andus, T; Chrissafidou, A; Malek, M; Musch, E; Schulz, M | 1 |
| Böcker, U; Singer, MV; Wenz, F; Zimmerer, T | 1 |
| Choi, HS; Hahm, JS; Han, DS; Joo, YW; Lee, HL; Lee, OY; Son, CN; Yoon, BC | 1 |
| Barr, A; Jeejeebhoy, KN; Patel, H | 1 |
| Bajpai, M; Das, KK; Das, KM; Geng, X; Kong, Y; Liu, J | 1 |
| Feller, ER; Harris, A; Shah, SA | 1 |
| Esposti, SD; Saha, S | 1 |
| Belluzzi, A; Bianchi, ML; Castellani, L; Grazia, M; Roda, E; Roda, G; Rosati, G; Serrani, M; Ugolini, G | 1 |
| Day, BJ; Dobis, DR; Gillespie, MM; Maier, LA; Newman, LS; Sawyer, RT | 1 |
| de Silva, S; Devlin, SM; Ghosh, S; Kaplan, GG; Panaccione, R; Seow, CH | 1 |
| Martínez-Reyes, C; Rodríguez-Reyna, TS; Yamamoto-Furusho, JK | 1 |
| Lal, R; Pilgrim, S; Tsiamis, A; Velchuru, V; Waters, G | 1 |
| Akobeng, AK; Beattie, RM; Casson, D; Croft, NM; Elawad, M; Fell, JM; Heuschkel, R; Jenkins, H; Johnson, T; Macdonald, S; Mitton, SG; Murch, SH; Murphy, MS; Newby, E; Sandhu, BK; Sawczenko, A; Thomas, AG; Wilson, DC | 1 |
| Das, K; Pitchumoni, CS; Rubin, A | 1 |
| Bachmann, O; Länger, F; Rademacher, J | 1 |
| Marinaki, AM; Sanderson, JD; Smith, MA | 1 |
| Azevedo, LF; Barros, L; Caldeira, P; Campos, M; Carvalho, L; Costa-Pereira, A; Cotter, J; Cravo, M; Cremers, I; Deus, J; Duarte, A; Gonçalves, R; Lago, P; Lopes, H; Lurdes, M; Magro, F; Ministro, P; Peixe, P; Portela, F; Reis, J; Vieira, A | 1 |
| Boulieu, R; Lachaux, A; Le Gall, C; Nguyen, TM | 1 |
| Das, KM; Kao, J; Kwok, K | 1 |
| Abe, T; Chiba, M; Fujiwara, K; Imai, H; Sugawara, T; Tozawa, H; Tsuda, H; Tsuda, S | 1 |
| Hu, PJ; Lin, XC; Tai, WP; Wu, J | 1 |
| Blagbrough, IS; Elmasry, MS; Kheir, AA; Rogers, PJ; Rowan, MG; Saleh, HM | 1 |
| Hanauer, S; Lim, WC | 1 |
| Chen, J; Gu, GZ; Jiang, XG; Liu, ZY; Pang, ZQ; Xia, HM | 1 |
| Achkar, JP; Ford, AC; Kane, SV; Khan, KJ; Marshall, JK; Moayyedi, P; Talley, NJ | 2 |
| Chidley, C; Haruki, H; Johnsson, K; Muller, E; Pedersen, MG | 1 |
| Blonski, W; Buchner, AM; Lichtenstein, GR | 1 |
| Bjerrum, JT; Munck, LK; Nielsen, OH | 1 |
| Klemt-Kropp, M; Uittenbogaart, SB | 1 |
| Balogh, M; David, G; Erdelyi, Z; Golovics, PA; Horvath, A; Kiss, LS; Komaromi, E; Lakatos, L; Lakatos, PL; Lovasz, BD; Mester, G; Molnar, C; Pandur, T; Szathmari, M; Szipocs, I; Veres, G | 1 |
| Bommelaer, G; Buisson, A; Chevaux, JB; Peyrin-Biroulet, L | 1 |
| Choi, CH; Jung, SA; Kim, WH; Kim, YH; Kim, YS; Lee, BI; Lee, H; Lee, KM; Ye, BD | 1 |
| Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD | 1 |
| Matsumoto, K; Umegae, S; Yamamoto, T | 1 |
| Ben-Horin, S; de Haar, C; Ehehalt, R; Higgins, P; Karrasch, T; Latella, G; Rieder, F; Rogler, G; Sans, M; Scaldaferri, F; Schirbel, A; Velin, D; Wehkamp, J | 1 |
| Asai, S; Masuda, H; Nishida, Y; Takahashi, Y | 1 |
| Cheon, JH; Hong, SP; Jung, YS; Kim, TI; Kim, WH; Park, SJ | 1 |
| Macdonald, JK; McDonald, JW; Timmer, A; Tsoulis, DJ | 1 |
| Feagan, BG; Macdonald, JK | 2 |
| Ahuja, V; Kumar, A; Kumar, S; Moss, AC; Sankar, MJ | 1 |
| Jambhrunkar, S; Kleitz, F; Liu, J; Popat, A; Qiao, SZ; Ross, BP | 1 |
| Busto Bea, V; Garrido, E; López San Román, A; Martínez González, J; Mesonero Gismero, F; Parejo Carbonell, S | 1 |
| Rothenberg, ME; Sonu, I; Wong, R | 1 |
| Akagi, M; Goishi, H; Kajihara, T; Miura, T; Sugiyama, S; Tanaka, T | 1 |
| Gaurav, V; Himanshu, R; Suneela, D | 1 |
| Kemp, A; Leong, RW; Selinger, CP | 1 |
| Dhaneshwar, SS | 1 |
| Ding, H; Hu, J; Hu, XY; Liu, XC; Mei, Q; Xu, JM | 1 |
| Guo, Y; Lei, S; Li, C; Lun, W; Ma, J; Zhao, X; Zhi, F | 1 |
| Hauso, Ø; Martinsen, TC; Waldum, H | 1 |
| Kesisoglou, F; Markopoulos, C; Reppas, C; Symillides, M; Vertzoni, M | 1 |
| El-Matary, W; Griffiths, AM; MacDonald, JK; Vandermeer, B; Wang, Y | 1 |
| Akbari, M; Moss, AC; OʼConnor, A; Packey, CD | 1 |
| Feng, S; Hao, Q; Hu, J; Huang, W; Li, Q; Liu, A; Liu, X; Wang, C; Wu, J; Yao, Y; Zhai, H; Zhang, S | 1 |
| Bhanji, T; Feagan, BG; MacDonald, JK; Parker, CE; Wang, Y | 1 |
| Feagan, BG; MacDonald, JK; Parker, CE; Wang, Y | 1 |
| Chande, N; MacDonald, JK; McDonald, JW; Patton, PH; Timmer, A | 1 |
| Grossman, AB; Maxwell, EC | 1 |
| Hanauer, S; Lim, WC; MacDonald, JK; Wang, Y | 1 |
| Imagawa, T; Ito, T; Kumagai, H; Miyauchi, A; Sakamoto, S; Tanaka, M; Tulyeu, J; Wada, S; Yamagata, T; Yokoyama, K | 1 |
| Arora, S; Mutneja, HR; Vij, A | 1 |
| Cappel, JA; Davis, DM; Gibson, LE; Schoch, JJ; Tolkachjov, SN | 1 |
| Kandula, M; Palanichamy, S; Rampal, A; Sunil Kumar, KB | 1 |
| Chande, N; MacDonald, JK; Parker, CE; Townsend, CM | 1 |
| Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W | 1 |
| Clement, F; Coward, S; Ghosh, S; Hazlewood, G; Holmes, R; Kaplan, GG; Kuenzig, ME; McBrien, K; Panaccione, R; Rezaie, A; Seow, CH | 1 |
| Barone, M; Cantarini, L; Fabiani, C; Franceschini, R; Frediani, B; Galeazzi, M; Iannone, F; Lapadula, G; Lopalco, G; Rigante, D; Venerito, V | 1 |
| Hanai, H; Hibi, T; Kochi, S; Nagahori, M; Nakamura, S; Omuro, S; Watanabe, M; Yamamoto, T | 1 |
| Kuriyama, A; Matsumura, M; Urushidani, S | 1 |
| Barski, L; Bartal, C; Sagy, I | 1 |
| Arito, M; Kato, T; Kurokawa, MS; Omoteyama, K; Sato, M; Sato, T; Suematsu, N | 1 |
| Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S | 1 |
| Dulai, PS; Fumery, M; Murad, MH; Nguyen, NH; Prokop, LJ; Sandborn, WJ; Singh, S | 1 |
| Binion, DG; Feuerstein, JD; Singh, S; Tremaine, WJ | 1 |
| Afif, W; Bernstein, CN; Bitton, A; Borgaonkar, M; Bressler, B; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Khanna, R; Leontiadis, GI; Loftus, EV; Marshall, JK; Meddings, J; Moayyedi, P; Murthy, S; Panaccione, R; Plamondon, S; Rosenfeld, G; Schwartz, D; Seow, CH; Steinhart, AH; Targownik, L; Williams, C | 1 |
| Itani, K; Soga, K | 1 |
| Bossa, F; Cassinotti, A; Danese, S; di Sabatino, A; Fiorino, G; Giuffrida, P; Sturniolo, GC | 1 |
| Chiang, BL; Hu, YC; Lee, JH; Lin, YT; Wang, LC; Yang, YH; Yu, HH | 1 |
| Ardizzone, S; Bezzio, C; Bosani, M; Carmagnola, S; Cassinotti, A; Chibbar, R; Dell'Era, A; Grillo, S; Landi, S; Maconi, G; Massari, A; Mezzina, N; Molteni, P; Pastorelli, L | 1 |
| Chu, AD; Deodhar, A; Everding, A; Kim, TH; Kishimoto, M; Maksymowych, WP; Pangan, AL; Sieper, J; Song, IH; Sui, Y; van den Bosch, F; van der Heijde, D; Wang, X | 1 |
| Cho, H; Heo, G; Im, E; Jeong, S; Ju, S; Jung, Y; Kim, HY; Kim, S; Kim, W; Lee, H; Yoo, JW; Yoon, IS | 1 |
| Kurosawa, K; Nagamoto, S; Ogawa, K; Oka, S; Okaneya, T; Sakaguchi, K; Urakami, S | 1 |
| Akobeng, AK; Baines, PA; Gordon, M; Iheozor-Ejiofor, Z; Kaur, L; Sinopoulou, V | 1 |
| Fujiwara, A; Higashi, R; Hiraoka, S; Inokuchi, T; Kato, J; Matsueda, K; Miyaike, J; Moritou, Y; Okada, H; Suzuki, S; Takagi, S; Takahara, M; Toyokawa, T | 1 |
| Feagan, BG; MacDonald, JK; Murray, A; Nguyen, TM; Parker, CE | 2 |
| Brenner, EJ; Colombel, JF; Focht, G; Kappelman, MD; Pigneur, B; Ruemmele, FM; Turner, D; Ungaro, RC; Zhang, X | 1 |
| Brusač, E; Jeličić, ML; Klarić, DA; Mornar, A; Nigović, B; Turk, N | 1 |
| Belluzzi, A; Calabrese, C; Calandrini, L; Decorato, A; Dussias, N; Filippone, E; Gionchetti, P; Laureti, S; Melotti, L; Peruzzi, G; Poggioli, G; Privitera, H; Rizzello, F; Rottoli, M; Salice, M; Scaioli, E; Siniscalchi, A | 1 |
| Ballester, MP; Martí-Aguado, D; Mínguez, M | 1 |
| Chen, S; Chen, Y; Cheng, J; Gu, P; Gu, Q; Hu, J; Ke, X; Liu, Y; Ren, S; Shen, H; Shen, Z; Tang, Z; Xie, J; Zhang, L; Zhang, S; Zhao, W; Zheng, K; Zhu, L; Zou, J | 1 |
| Furey, TS; Roy, S; Sheikh, SZ | 1 |
| Agrawal, M; Brenner, EJ; Colombel, JF; Kappelman, MD; Ungaro, RC; Zhang, X | 1 |
| Jairath, V; Ma, C; Sedano, R | 1 |
| Al Awadhi, S; Begun, J; Cheon, JH; Dignass, AU; Freddi, MJ; Louis, E; Magro, F; Márquez, JR; Moschen, AR; Narula, N; Paridaens, K; Rydzewska, G; Travis, SP | 1 |
| Guardiola, J; Rodríguez-Alonso, L; Rodríguez-Moranta, F; Ruiz-Cerulla, A | 1 |
| Feagan, BG; Hogan, M; Jairath, V; Ma, C; Narula, N; Sedano, R; Singh, S; Zou, G | 1 |
| Du, Y; Gao, B; Gong, Y; Ji, C; Li, HS; Wang, J; Wu, P | 1 |
| Kanai, T; Kiyohara, H; Mikami, Y; Mizushima, I; Suzuki, S; Tsunoda, J | 1 |
| Bousvaros, A; Chan, C; Liu, E; Mansuri, I; Rufo, PA; Wang, S | 1 |
| Eizuka, K; Honta, S; Ikehata, A; Inomata, N; Masuo, T; Ono, S; Sekino, Y | 1 |
138 review(s) available for mesalamine and sulfasalazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Long-term therapy and timing of surgical intervention in ulcerative colitis and Crohn disease].
Topics: Acute Disease; Aminosalicylic Acids; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Follow-Up Studies; Humans; Long-Term Care; Mesalamine; Sulfasalazine | 1992 |
[Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Sulfasalazine | 1992 |
Sulfasalazine. Multiplicity of action.
Topics: Aminosalicylic Acids; Animals; Free Radical Scavengers; Humans; Hydroxyeicosatetraenoic Acids; Inflammatory Bowel Diseases; Leukocytes; Lipoxygenase Inhibitors; Mesalamine; Prostaglandin Antagonists; Sulfapyridine; Sulfasalazine | 1992 |
Maintenance treatment for Crohn's disease: has the time arrived?
Topics: Aminosalicylic Acids; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 1992 |
Sulfasalazine and 5-ASA compounds.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Combinations; Humans; Mesalamine; Sulfasalazine | 1992 |
Outpatient management of inflammatory bowel disease. Let's keep it as simple as possible.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acids; Anus Diseases; Diarrhea; Dyspepsia; Fever; Gastrointestinal Hemorrhage; Humans; Inflammatory Bowel Diseases; Mesalamine; Office Visits; Psychotherapy; Sulfasalazine; Tuberculosis | 1992 |
Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Cytokines; Eicosapentaenoic Acid; Fish Oils; Humans; Interleukins; Leukotriene B4; Mesalamine; Sulfasalazine | 1992 |
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Animals; Arachidonic Acid; Disease Models, Animal; Double-Blind Method; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Mesalamine; Sulfasalazine | 1992 |
Sulphasalazine in ulcerative colitis: in memoriam?
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Mesalamine; Neutrophils; Sulfapyridine; Sulfasalazine | 1991 |
Mesalamine in ulcerative colitis.
Topics: Administration, Rectal; Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Costs and Cost Analysis; Enema; Humans; Mesalamine; Remission Induction; Sulfasalazine | 1991 |
[New salicylic acid derivatives in the treatment of inflammatory intestinal diseases].
Topics: Aminosalicylic Acids; Chronic Disease; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 1991 |
[Conservative therapy of Crohn disease--reliable measures based on clinical studies].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1991 |
[Conservative therapy of ulcerative colitis--long-term experience].
Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Prognosis; Sulfasalazine | 1991 |
[Experiences with phase III studies in the area of gastroenterology].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 1991 |
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1990 |
Topical treatment of ulcerative colitis.
Topics: Absorption; Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Cromolyn Sodium; Dose-Response Relationship, Drug; Enema; Evaluation Studies as Topic; Humans; Mesalamine; Sucralfate; Sulfasalazine; Suppositories | 1990 |
The role of mesalazine in Crohn's disease.
Topics: Aminosalicylic Acids; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1990 |
Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Mesalamine; Oxygen; Phagocytes; Sulfasalazine | 1990 |
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen.
Topics: Abdomen, Acute; Adrenocorticotropic Hormone; Adult; Aminosalicylic Acids; Cortisone; Diagnosis, Differential; Female; Hemorrhage; Humans; Hydrocortisone; Inflammatory Bowel Diseases; Male; Mesalamine; Prednisone; Sulfasalazine; Tomography, X-Ray Computed; Ultrasonography | 1990 |
New salicylate therapies for ulcerative colitis.
Topics: Administration, Oral; Administration, Rectal; Aminosalicylic Acid; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1990 |
Topical salicylate therapy (4-ASA and 5-ASA enemas).
Topics: Administration, Topical; Aminosalicylic Acid; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Enema; Humans; Mesalamine; Sulfasalazine | 1989 |
Oral 5-aminosalicyclic acid in children with colonic chronic inflammatory bowel disease: clinical and pharmacokinetic experience.
Topics: Administration, Oral; Adolescent; Aminosalicylic Acids; Chronic Disease; Colitis; Drug Tolerance; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Sulfasalazine | 1989 |
Inflammatory bowel disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Delayed-Action Preparations; Drug Evaluation; Forecasting; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole; Sulfasalazine | 1989 |
Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Mesalamine; Prostaglandins; Sulfasalazine; Thromboxane B2 | 1989 |
[Prevention of recurrence of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Long-Term Care; Mesalamine; Prednisone; Recurrence; Sulfasalazine | 1989 |
Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Drug Combinations; Drug Interactions; Enema; Female; Folic Acid; Glucosamine; Humans; Mesalamine; Pregnancy; Sulfapyridine; Sulfasalazine | 1985 |
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
Topics: Administration, Oral; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1987 |
[New forms of 5-aminosalicylate in inflammatory intestinal lesions].
Topics: Aminosalicylic Acids; Drug Combinations; Glucosamine; Humans; Inflammation; Intestinal Diseases; Mesalamine; Sulfasalazine | 1987 |
Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Food, Formulated; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Parenteral Nutrition, Total; Sulfasalazine | 1987 |
Update on the aminosalicylates: a promise fulfilled.
Topics: Aminosalicylic Acids; Canada; Europe; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine; United States | 1988 |
[Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1988 |
[Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Mucosa; Leukotriene Antagonists; Mesalamine; Sulfasalazine | 1988 |
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
Topics: Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Interactions; Enema; Female; Humans; Intestinal Absorption; Male; Maternal-Fetal Exchange; Mesalamine; Milk, Human; Pregnancy; Sulfasalazine; Suppositories; Tissue Distribution | 1984 |
Medical treatment of ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenocorticotropic Hormone; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Diet; Humans; Injections, Intravenous; Mesalamine; Physician's Role; Prednisolone; Sulfasalazine | 1984 |
Collagenous and lymphocytic colitis: subject review and therapeutic alternatives.
Topics: Algorithms; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colitis; Colon; Diarrhea; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1995 |
Pharmacologic therapy for inflammatory bowel disease.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Enema; Humans; Hydrocortisone; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine; Suppositories | 1995 |
[Current orientation in medical management of ulcerative colitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Sulfasalazine | 1995 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
Rolling review: inflammatory bowel disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Steroids; Sulfasalazine | 1993 |
[The treatment of ulcerative colitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1993 |
[Current medical treatment of hemorrhagic rectocolitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Mesalamine; Sulfasalazine | 1994 |
Medical management of Crohn's disease in childhood.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Child; Combined Modality Therapy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Parenteral Nutrition; Sulfasalazine | 1994 |
Medical therapy for ulcerative colitis in childhood.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Child; Child, Preschool; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Infant; Intestinal Mucosa; Mercaptopurine; Mesalamine; Sulfasalazine | 1994 |
Salicylates for inflammatory bowel disease.
Topics: Aminosalicylic Acids; Controlled Clinical Trials as Topic; Humans; Inflammatory Bowel Diseases; Mesalamine; Randomized Controlled Trials as Topic; Salicylates; Sulfasalazine | 1994 |
Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1994 |
Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Odds Ratio; Randomized Controlled Trials as Topic; Sulfasalazine | 1993 |
[Local or systemic treatment of inflammatory bowel diseases?].
Topics: Administration, Oral; Administration, Rectal; Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Humans; Mesalamine; Steroids; Sulfasalazine | 1993 |
[The local therapy of distal colitis and ulcerative proctitis].
Topics: Administration, Rectal; Aminosalicylic Acids; Colitis; Colitis, Ulcerative; Cromolyn Sodium; Fatty Acids, Volatile; Glucocorticoids; Humans; Mesalamine; Sucralfate; Sulfasalazine | 1993 |
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Mesalamine; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Steroids; Sulfasalazine; Treatment Outcome | 1993 |
Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 1993 |
Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Humans; Mesalamine; Sulfapyridine; Sulfasalazine | 1995 |
[Treatment and recurrence prevention ulcerative colitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Humans; Mesalamine; Recurrence; Sulfasalazine | 1995 |
[Drug therapy of ulcerative colitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Sulfasalazine | 1997 |
Guidelines for the treatment of ulcerative colitis in remission.
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mesalamine; Sulfasalazine | 1997 |
Intestinal fate of 5-aminosalicylic acid: regional and systemic kinetic studies in relation to inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Sulfasalazine | 1997 |
A practical guide to the management of distal ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lipoxygenase Inhibitors; Mesalamine; Quality of Life; Salicylates; Sulfasalazine | 1998 |
The treatment of inflammatory bowel disease in children.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Metronidazole; Sulfasalazine | 1998 |
Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Hypersensitivity; Humans; Male; Mesalamine; Pericarditis; Prednisone; Recurrence; Sulfasalazine | 1998 |
Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Glucocorticoids; Humans; Mesalamine; Meta-Analysis as Topic; Prednisolone; Sulfasalazine; Treatment Outcome | 1998 |
[A case of ulcerative colitis with folate deficient megaloblastic anemia induced by sulfasalazine].
Topics: Adult; Anemia, Megaloblastic; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Folic Acid Deficiency; Humans; Male; Mesalamine; Sulfasalazine | 1999 |
[Medical therapy in ulcerative colitis].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colitis, Ulcerative; Diet Therapy; Humans; Leukapheresis; Life Style; Mesalamine; Methylprednisolone; Prednisolone; Sulfasalazine | 1999 |
[Salazosulfapyridine and 5-aminosalicylic acid agents for the treatment of ulcerative colitis].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Cytokines; Depression, Chemical; Drug Delivery Systems; Histamine Release; HLA-DR Antigens; Humans; Leukotriene B4; Lipid Peroxidation; Mesalamine; Nitric Oxide; Sulfasalazine | 1999 |
[Present states of development in new drugs and treatment of inflammatory bowel disease].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Leukapheresis; Mesalamine; Mice; Oligonucleotides, Antisense; Sulfasalazine; Tumor Necrosis Factor-alpha | 1999 |
[Treatment of mild and moderate ulcerative colitis].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Colitis, Ulcerative; Drug Therapy, Combination; Enteral Nutrition; Follow-Up Studies; Humans; Mesalamine; Parenteral Nutrition; Prednisolone; Severity of Illness Index; Sulfasalazine | 1999 |
[Cardio vascular disease associated with ulcerative colitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; HLA-B Antigens; HLA-B52 Antigen; HLA-DR2 Antigen; Humans; Male; Mesalamine; Myocarditis; Pericarditis; Sulfasalazine; Takayasu Arteritis | 1999 |
[Clinical features and management of the elderly patients with ulcerative colitis].
Topics: Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Humans; Megacolon, Toxic; Mesalamine; Pulmonary Embolism; Severity of Illness Index; Skin Diseases; Sulfasalazine | 1999 |
[Ulcerative colitis and pregnancy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Fertility; Humans; Immunosuppressive Agents; Maternal-Fetal Exchange; Mesalamine; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sulfasalazine | 1999 |
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors | 1999 |
Medical therapy to reduce postoperative Crohn's disease recurrence.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Recurrence; Risk Factors; Sulfasalazine | 2000 |
Comparative tolerability of treatments for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Pregnancy; Prodrugs; Sulfasalazine | 2000 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome | 2001 |
Inflammatory bowel disease and pregnancy.
Topics: Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Female; Fertility; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Patient Education as Topic; Pregnancy; Pregnancy Complications; Sulfasalazine; Surgical Procedures, Operative | 2001 |
Conventional treatments for ankylosing spondylitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Azathioprine; Diphosphonates; Exercise Therapy; Gold; Humans; Mesalamine; Pain; Pamidronate; Patient Education as Topic; Physical Therapy Modalities; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2002 |
Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
Topics: Acute Disease; Administration, Oral; Administration, Rectal; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Enema; Humans; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine; Time Factors | 2002 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Remission Induction; Sulfasalazine | 2002 |
[Conservative therapy of inflammatory bowel diseases].
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Prednisolone; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2002 |
Review article: medical treatment of mild to moderately active Crohn's disease.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mesalamine; Rectal Diseases; Sulfasalazine | 2003 |
Review article: maintenance treatment of Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Mesalamine; Phenylhydrazines; Remission Induction; Secondary Prevention; Sulfasalazine; Tumor Necrosis Factor-alpha | 2003 |
Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.
Topics: Administration, Topical; Algorithms; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Controlled Clinical Trials as Topic; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Mesalamine; Sulfasalazine | 2003 |
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine | 2003 |
The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Clinical Trials as Topic; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Labeling; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Product Surveillance, Postmarketing; Sensitivity and Specificity; Sulfasalazine | 2004 |
Controversies with aminosalicylates in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Chemoprevention; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Dose-Response Relationship, Drug; Gastrointestinal Agents; Humans; Infliximab; Mesalamine; Remission Induction; Sulfasalazine | 2004 |
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Remission Induction; Secondary Prevention; Sulfasalazine | 2005 |
[Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
Topics: Administration, Oral; Colitis, Ulcerative; Drug Administration Schedule; Enema; Humans; Mesalamine; Sulfasalazine; Suppositories | 2005 |
Systematic review: the use of mesalazine in inflammatory bowel disease.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Drug Administration Schedule; Humans; Inflammatory Bowel Diseases; Mesalamine; Patient Compliance; Sulfasalazine; Treatment Outcome | 2006 |
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine | 2006 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine | 2006 |
Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chemoprevention; Clinical Trials as Topic; Colitis, Ulcerative; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mesalamine; Patient Compliance; Phenylhydrazines; Remission Induction; Sulfasalazine | 2006 |
Pharmacogenetics in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome | 2006 |
The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Topics: Acute Disease; Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diverticulitis, Colonic; Dose-Response Relationship, Drug; Humans; Mesalamine; Sulfasalazine | 2006 |
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
Topics: Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Humans; Mesalamine; Mice; Patient Compliance; Peroxisome Proliferator-Activated Receptors; Sulfasalazine | 2006 |
Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Administration Schedule; Humans; Mesalamine; Remission Induction; Sulfasalazine; Treatment Outcome | 2006 |
Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Colonic Neoplasms; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine; Treatment Failure; Treatment Refusal | 2006 |
[Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Humans; Male; Mesalamine; Middle Aged; Pedigree; Sulfasalazine; Treatment Outcome | 2006 |
Drug insight: aminosalicylates for the treatment of IBD.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Drug Interactions; Female; Fertility; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Pregnancy; Remission Induction; Sulfasalazine | 2007 |
Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antidiarrheals; Female; Fish Oils; Glucocorticoids; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Mesalamine; Postpartum Period; Pregnancy; Pregnancy Complications; Probiotics; Sulfasalazine | 2007 |
Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review.
Topics: Abdominal Neoplasms; Acute Disease; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Diarrhea; Double-Blind Method; Enteritis; Humans; Intestinal Mucosa; Loperamide; Mesalamine; Octreotide; Parenteral Nutrition, Home; Pelvic Neoplasms; Pentoxifylline; Probiotics; Radiation Injuries; Sulfasalazine; Tocopherols | 2008 |
Reproductive issues in inflammatory bowel disease.
Topics: Adaptation, Psychological; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Pregnancy; Pregnancy Complications; Reproductive Behavior; Stress, Psychological; Sulfasalazine | 2009 |
Rheumatic manifestations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cadherins; Cytokines; Gastroenterology; Humans; Inflammation; Inflammatory Bowel Diseases; Intestines; Mesalamine; Permeability; Rheumatic Diseases; Spondylitis; Sulfasalazine; Tumor Necrosis Factor-alpha | 2009 |
Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Child; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Remission Induction; Sulfasalazine | 2010 |
Pancreatitis in inflammatory bowel diseases.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Pancreatitis; Sulfasalazine | 2010 |
[Pulmonary manifestations of inflammatory bowel disease].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Bronchoscopy; Chest Pain; Colitis, Ulcerative; Cough; Crohn Disease; Dyspnea; Humans; Immunosuppressive Agents; Infliximab; Lung Diseases; Mesalamine; Sulfasalazine; Tomography, X-Ray Computed | 2010 |
Pharmacogenomics in the treatment of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cytokines; Drug Monitoring; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Inosine Triphosphatase; Mesalamine; Methyltransferases; Pharmacogenetics; Pyrophosphatases; Receptors, Glucocorticoid; Sulfasalazine | 2010 |
Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mesalamine; Remission Induction; Sulfasalazine | 2010 |
Aminosalicylates for induction of remission or response in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine | 2010 |
Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Risk; Secondary Prevention; Sulfasalazine; Treatment Failure; Treatment Outcome | 2011 |
Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Risk Reduction Behavior; Secondary Prevention; Sulfasalazine; Treatment Outcome | 2011 |
Update on the management of Crohn's disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Budesonide; Crohn Disease; Humans; Immunologic Factors; Immunosuppressive Agents; Mesalamine; Methotrexate; Natalizumab; Sulfasalazine; Tumor Necrosis Factor-alpha | 2011 |
[5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Evidence-Based Medicine; Humans; Mesalamine; Remission Induction; Sulfasalazine; Treatment Outcome | 2011 |
Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.
Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Biomarkers; Capsule Endoscopy; Colonoscopy; Crohn Disease; Enteral Nutrition; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Imaging; Mesalamine; Secondary Prevention; Sulfasalazine; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Ultrasonography | 2012 |
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Butyric Acid; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Defensins; Extracellular Matrix; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Leptin; Matrix Metalloproteinases; Mesalamine; Paneth Cells; Probiotics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfasalazine; Tumor Necrosis Factor-alpha; Wound Healing | 2012 |
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine | 2012 |
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Induction Chemotherapy; Mesalamine; Randomized Controlled Trials as Topic; Sulfasalazine; Treatment Failure | 2012 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Medication Adherence; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sulfasalazine | 2012 |
Curcumin for maintenance of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Drug Therapy, Combination; Humans; Maintenance Chemotherapy; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 2012 |
Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Clinical Trials as Topic; Colon; Fatty Acids, Omega-3; Heparin, Low-Molecular-Weight; Humans; Inflammatory Bowel Diseases; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine | 2014 |
5-Aminosalicylic acid, a specific drug for ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colon; Humans; Inflammation; Mesalamine; Remission Induction; Sulfasalazine | 2015 |
Methotrexate for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Sulfasalazine | 2015 |
Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Mesalamine; Risk Assessment; Sulfasalazine | 2015 |
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Induction Chemotherapy; Mesalamine; Randomized Controlled Trials as Topic; Sulfasalazine; Treatment Failure | 2016 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Medication Adherence; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sulfasalazine | 2016 |
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine | 2016 |
Advances in Pediatric Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus | 2016 |
Aminosalicylates for induction of remission or response in Crohn's disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Delayed-Action Preparations; Gastrointestinal Agents; Humans; Induction Chemotherapy; Mesalamine; Randomized Controlled Trials as Topic; Sulfasalazine | 2016 |
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Topics: Adult; Antimetabolites; Azathioprine; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Sulfasalazine; Withholding Treatment | 2016 |
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Bayes Theorem; Budesonide; Comparative Effectiveness Research; Crohn Disease; Humans; Induction Chemotherapy; Mesalamine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Sulfasalazine; Treatment Outcome | 2017 |
Update on the Medical Management of Gastrointestinal Behçet's Disease.
Topics: Adrenal Cortex Hormones; Animals; Behcet Syndrome; Gastrointestinal Tract; Humans; Immunologic Factors; Mesalamine; Sulfasalazine; Thalidomide | 2017 |
5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents; Databases, Bibliographic; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sulfasalazine; Treatment Outcome; Young Adult | 2018 |
Drug-induced eosinophilic pneumonia: A review of 196 case reports.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Daptomycin; Eosinophils; Female; Humans; Male; Mesalamine; Middle Aged; Minocycline; Pulmonary Eosinophilia; Sulfasalazine | 2018 |
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.
Topics: Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Colitis, Ulcerative; Humans; Mesalamine; Network Meta-Analysis; Remission Induction; Sulfasalazine | 2018 |
AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Management; Disease Progression; Female; Gastroenterology; Humans; Male; Mesalamine; Prognosis; Risk Assessment; Severity of Illness Index; Societies, Medical; Sulfasalazine; Treatment Outcome; United States | 2019 |
Probiotics for induction of remission in ulcerative colitis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bias; Child; Colitis, Ulcerative; Combined Modality Therapy; Humans; Mesalamine; Middle Aged; Numbers Needed To Treat; Probiotics; Randomized Controlled Trials as Topic; Remission Induction; Sample Size; Sulfasalazine | 2020 |
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Bias; Colitis, Ulcerative; Drug Administration Schedule; Humans; Induction Chemotherapy; Mesalamine; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine; Treatment Failure | 2020 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Bias; Colitis, Ulcerative; Drug Administration Schedule; Humans; Maintenance Chemotherapy; Medication Adherence; Mesalamine; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sulfasalazine | 2020 |
Risk factors and management strategies associated with non-response to aminosalicylates as a maintenance treatment in ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Risk Factors; Sulfasalazine | 2021 |
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis.
Topics: Abdominal Pain; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Fever; Genome-Wide Association Study; Humans; Mesalamine; Remission Induction; Sulfasalazine | 2023 |
64 trial(s) available for mesalamine and sulfasalazine
| Article | Year |
|---|---|
Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
Topics: Aminosalicylic Acids; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1992 |
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Leukotriene B4; Male; Mesalamine; Middle Aged; Olive Oil; Plant Oils; Prednisolone; Prospective Studies; Remission Induction; Sulfasalazine | 1992 |
Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Colitis, Ulcerative; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Sulfasalazine | 1992 |
Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea.
Topics: Adult; Aged; Aminosalicylic Acids; Delayed-Action Preparations; Diarrhea; Drug Carriers; Feces; Female; Gastrointestinal Transit; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Sulfasalazine | 1992 |
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Animals; Arachidonic Acid; Disease Models, Animal; Double-Blind Method; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Mesalamine; Sulfasalazine | 1992 |
Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Effect of in vivo administration and an in vitro analysis.
Topics: Aminosalicylic Acids; Double-Blind Method; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Mesalamine; Neutrophils; Oxygen; Sulfasalazine | 1991 |
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1990 |
Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 1990 |
Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Double-Blind Method; Humans; Immunosuppressive Agents; Killer Cells, Natural; Mesalamine; Random Allocation; Sulfasalazine | 1990 |
Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Gastroscopy; Humans; Mesalamine; Stomach; Sulfasalazine; Time Factors | 1990 |
Aminosalicylates: old and new.
Topics: Administration, Oral; Aminosalicylic Acids; Enema; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 1990 |
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Multicenter Studies as Topic; Random Allocation; Remission Induction; Sulfasalazine; Tablets, Enteric-Coated | 1989 |
Effects of mesalazine substitution on salicylazosulfapyridine-induced seminal abnormalities in men with ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Delayed-Action Preparations; Humans; Male; Mesalamine; Middle Aged; Semen; Sperm Motility; Sulfasalazine | 1989 |
Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid-delivering drugs during accelerated intestinal transit in healthy volunteers.
Topics: Adult; Aminosalicylic Acids; Bisacodyl; Female; Gastrointestinal Transit; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1989 |
[Prevention of recurrence of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Long-Term Care; Mesalamine; Prednisone; Recurrence; Sulfasalazine | 1989 |
Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Sulfasalazine | 1989 |
[Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Mesalamine; Methylprednisolone; Middle Aged; Statistics as Topic; Sulfasalazine | 1985 |
Which component of sulphasalazine is active in rheumatoid arthritis?
Topics: Adult; Aged; Aminosalicylic Acids; Arthritis, Rheumatoid; Humans; Mesalamine; Middle Aged; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1985 |
Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1985 |
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.
Topics: Aminosalicylic Acids; Colectomy; Delayed-Action Preparations; Feces; Humans; Ileum; Mesalamine; Rectum; Sulfasalazine | 1986 |
[Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporins; Humans; Mesalamine; Metronidazole; Sulfasalazine | 1986 |
Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Sulfapyridine; Sulfasalazine | 1987 |
Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine; Sulfonamides | 1987 |
Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
Topics: Administration, Oral; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1987 |
Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Sulfasalazine | 1988 |
Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
Topics: Adult; Aminosalicylic Acids; Azo Compounds; Delayed-Action Preparations; Feces; Female; Humans; Male; Mesalamine; Sulfasalazine | 1988 |
Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Delayed-Action Preparations; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine; Tablets, Enteric-Coated | 1988 |
Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mesalamine; Middle Aged; Random Allocation; Recurrence; Sulfasalazine | 1988 |
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis.
Topics: Actuarial Analysis; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Multicenter Studies as Topic; Random Allocation; Sulfasalazine; Tablets, Enteric-Coated; Time Factors | 1988 |
Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones.
Topics: Adult; Aminosalicylic Acids; Gonadal Steroid Hormones; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Semen; Sperm Count; Sperm Motility; Sulfasalazine; Testosterone | 1988 |
Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Sulfasalazine | 1988 |
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
Topics: Acrylic Resins; Administration, Oral; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Polymethacrylic Acids; Random Allocation; Recurrence; Sulfasalazine; Tablets, Enteric-Coated | 1982 |
The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.
Topics: Acetylation; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Mesalamine; Methemoglobinemia; Phenotype; Polymorphism, Genetic; Prednisolone; Random Allocation; Sulfasalazine | 1983 |
Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mesalamine; Middle Aged; Random Allocation; Sulfasalazine | 1983 |
Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man.
Topics: Adult; Aged; Aminosalicylic Acids; Bile; Biliary Tract Diseases; Colitis, Ulcerative; Crohn Disease; Humans; Kinetics; Mesalamine; Middle Aged; Sulfasalazine | 1983 |
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
Topics: Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Interactions; Enema; Female; Humans; Intestinal Absorption; Male; Maternal-Fetal Exchange; Mesalamine; Milk, Human; Pregnancy; Sulfasalazine; Suppositories; Tissue Distribution | 1984 |
Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man.
Topics: Aminosalicylic Acids; Animals; Clinical Trials as Topic; Crohn Disease; Humans; Kidney; Male; Mesalamine; Rats; Rats, Inbred Strains; Sulfasalazine | 1984 |
Management of perianal Crohn's disease. Results of a multicenter study in Italy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anus Diseases; Child; Colostomy; Crohn Disease; Female; Follow-Up Studies; Humans; Ileostomy; Male; Mesalamine; Metronidazole; Middle Aged; Reoperation; Sulfasalazine; Treatment Outcome | 1995 |
5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Drug Administration Schedule; Enema; Female; Follow-Up Studies; Humans; Male; Mesalamine; Prospective Studies; Recurrence; Sulfasalazine; Time Factors | 1994 |
Response to treatment of microscopic colitis.
Topics: Aminosalicylic Acids; Colitis; Colon; Diarrhea; Drug Therapy, Combination; Eosinophils; Female; Follow-Up Studies; Humans; Lymphocytes; Male; Mesalamine; Middle Aged; Prednisolone; Rectum; Retrospective Studies; Sulfasalazine; Time Factors | 1994 |
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Mesalamine; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Steroids; Sulfasalazine; Treatment Outcome | 1993 |
An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Mesalamine; Patient Compliance; Polymers; Remission Induction; Sulfasalazine; Tablets, Enteric-Coated; Time Factors; Treatment Outcome | 1996 |
Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mesalamine; Sulfasalazine | 1995 |
Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Topics: Adverse Drug Reaction Reporting Systems; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Female; Humans; Japan; Male; Mesalamine; Sulfasalazine | 1995 |
Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
Topics: Acrylic Resins; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Drug Administration Schedule; Female; Humans; Life Tables; Male; Mesalamine; Polymethacrylic Acids; Prospective Studies; Recurrence; Sulfasalazine; Tablets, Enteric-Coated; Time Factors | 1995 |
A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Enema; Female; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Remission Induction; Sulfasalazine; Suspensions | 1996 |
Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized, controlled study.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Dermatologic Agents; Female; Humans; Male; Mesalamine; Middle Aged; Pain; Single-Blind Method; Spondylitis, Ankylosing; Sulfapyridine; Sulfasalazine | 1996 |
5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine.
Topics: Absorption; Acetylation; Acetylglucosaminidase; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1996 |
Is maintenance therapy always necessary for patients with ulcerative colitis in remission?
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Patient Compliance; Secondary Prevention; Sulfasalazine | 1999 |
[Salozinal in the treatment of the irritable bowel syndrome in young persons].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Biopsy; Colon; Colonic Diseases, Functional; Colonoscopy; Fiber Optic Technology; Humans; Immunity, Cellular; Lipid Peroxidation; Mesalamine; Sulfasalazine; Treatment Outcome | 1999 |
Treatment of spondyloarthropathy with 5-aminosalicylic acid (mesalazine): an open trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Blood Sedimentation; Female; Humans; Male; Mesalamine; Middle Aged; Pilot Projects; Retreatment; Spondylitis; Sulfasalazine; Treatment Outcome | 2000 |
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Breath Tests; Colitis, Ulcerative; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Prevalence; Prospective Studies; Sulfasalazine | 2000 |
A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Severity of Illness Index; Sigmoidoscopy; Sulfasalazine; Treatment Outcome | 2002 |
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Severity of Illness Index; Sigmoidoscopy; Sulfasalazine; Treatment Outcome | 2002 |
Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Crohn Disease; Drug Interactions; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mesalamine; Methyltransferases; Middle Aged; Sulfasalazine; Thionucleotides | 2002 |
[Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].
Topics: Adult; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Recurrence; Sulfasalazine; Treatment Outcome | 2003 |
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Curcumin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome | 2006 |
Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunologic Factors; Infusions, Intravenous; Interferon-beta; Long-Term Care; Male; Mesalamine; Middle Aged; Secondary Prevention; Sigmoidoscopy; Sulfasalazine | 2007 |
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis.
Topics: Adult; Colonic Pouches; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Pilot Projects; Pouchitis; Proctocolectomy, Restorative; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Young Adult | 2010 |
Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Diet, Vegetarian; Female; Humans; Kaplan-Meier Estimate; Life Style; Male; Mesalamine; Middle Aged; Prospective Studies; Remission Induction; Secondary Prevention; Sulfasalazine; Young Adult | 2010 |
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.
Topics: Adult; Capsules; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Endoscopy; Female; Humans; Male; Mesalamine; Middle Aged; Placebos; Remission Induction; Sulfasalazine; Treatment Outcome | 2019 |
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Topics: Adult; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; Humans; Hydroxychloroquine; Janus Kinase Inhibitors; Magnetic Resonance Imaging; Male; Mesalamine; Methotrexate; Middle Aged; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2019 |
Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis.
Topics: Adult; Anti-Ulcer Agents; Colitis, Ulcerative; Double-Blind Method; Drugs, Chinese Herbal; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Prospective Studies; Quality of Life; Sulfasalazine; Treatment Outcome | 2021 |
307 other study(ies) available for mesalamine and sulfasalazine
| Article | Year |
|---|---|
A polymeric drug for treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acid; Animals; Biotransformation; Colitis, Ulcerative; Guinea Pigs; Intestines; Polymers; Salicylates; Sulfapyridine; Sulfasalazine | 1983 |
Brush-border-enzyme-mediated intestine-specific drug delivery. Amino acid prodrugs of 5-aminosalicylic acid.
Topics: Amino Acids; Aminopeptidases; Aminosalicylic Acids; Animals; Carboxypeptidases; Colon; Colostomy; Feces; Glutamyl Aminopeptidase; Hydrolysis; Ileum; Inflammatory Bowel Diseases; Intestinal Absorption; Intestines; Kinetics; Male; Mesalamine; Microvilli; Prodrugs; Rats | 1993 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Female; Male; Molecular Structure; Organ Specificity; Prodrugs; Rats; Rats, Wistar | 2007 |
Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.
Topics: Animals; Chemistry, Pharmaceutical; Colon; Drug Delivery Systems; Drug Design; Hydrochloric Acid; Inflammatory Bowel Diseases; Kinetics; Mesalamine; Models, Chemical; Molecular Conformation; Phenylalanine; Prodrugs; Rats; Sulfasalazine | 2007 |
Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Animals; Azo Compounds; Body Weight; Colitis; Kinetics; Mesalamine; Molecular Structure; Organ Size; Prodrugs; Rats; Trinitrobenzenesulfonic Acid; Tryptophan | 2007 |
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
Topics: Aminosalicylic Acids; Animals; Colitis; Colon; Drug Delivery Systems; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Liver; Pancreas; Prodrugs; Rats; Ulcer | 2009 |
Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Animals; Arthritis; Colitis; Colon; Female; Inflammatory Bowel Diseases; Male; Peroxidase; Prodrugs; Rats; Rats, Wistar; Ulcer | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of xc⁻ transporter-mediated cystine uptake by sulfasalazine analogs.
Topics: Amino Acid Transport System X-AG; Antiporters; Cell Line; Cystine; Humans; Structure-Activity Relationship; Sulfasalazine | 2011 |
Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
Topics: Animals; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Glucosides; Male; Molecular Structure; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2016 |
In vitro and in vivo inhibitory activity of 6-amino-2,4,5-trimethylpyridin-3-ols against inflammatory bowel disease.
Topics: Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Pyridines | 2016 |
Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease.
Topics: Animals; Benzofurans; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Female; HT29 Cells; Humans; Indenes; Inflammatory Bowel Diseases; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; U937 Cells | 2017 |
Synthesis and biological evaluation of pyridine-linked indanone derivatives: Potential agents for inflammatory bowel disease.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; HT29 Cells; Humans; Indans; Inflammatory Bowel Diseases; Molecular Structure; Monocytes; Pyridines; Rats; Structure-Activity Relationship; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2018 |
Synthesis and evaluation of 6-heteroarylamino-2,4,5-trimethylpyridin-3-ols as inhibitors of TNF-α-induced cell adhesion and inflammatory bowel disease.
Topics: | 2018 |
Synthesis and activity of N-(5-hydroxy-3,4,6-trimethylpyridin-2-yl)acetamide analogues as anticolitis agents via dual inhibition of TNF-α- and IL-6-induced cell adhesions.
Topics: Acetamides; Animals; Cell Adhesion; Colitis; Dose-Response Relationship, Drug; Interleukin-6; Molecular Structure; Rats; Structure-Activity Relationship; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2021 |
The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
Topics: Aminosalicylic Acids; Animals; Cattle; Cell Count; Cell Cycle; Deoxyuridine; Endothelium, Vascular; Mesalamine; Sulfapyridine; Sulfasalazine; Tetrahydrofolates; Thymidine; Time Factors; Tritium | 1992 |
Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine.
Topics: Aminosalicylic Acids; Drug Hypersensitivity; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Phenylhydrazines; Sulfapyridine; Sulfasalazine | 1992 |
Induction of colitis in rats by 2-2'-azobis(2-amidinopropane) dihydrochloride.
Topics: Amidines; Aminosalicylic Acids; Animals; Benzopyrans; Colitis; Inflammation; Intestinal Mucosa; Lipid Peroxidation; Male; Mesalamine; Oxidation-Reduction; Peroxidase; Rats; Rats, Inbred Strains; Sulfasalazine; Sulfhydryl Compounds; Thiobarbiturates | 1992 |
Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Topics: Acrylic Resins; Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies; Sulfasalazine; Tablets, Enteric-Coated | 1992 |
A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine.
Topics: Adult; Aminosalicylic Acids; Chemistry, Pharmaceutical; Delayed-Action Preparations; Humans; Male; Mesalamine; Middle Aged; Polymers; Sulfasalazine; Tablets, Enteric-Coated | 1992 |
The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Lipopolysaccharides; Male; Mesalamine; Monocytes; Prostaglandins; Sulfasalazine | 1992 |
Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Chronic Disease; Desensitization, Immunologic; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Stevens-Johnson Syndrome; Sulfasalazine | 1992 |
Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis; Colon; Disease Models, Animal; Humans; Interleukin-1; Male; Mesalamine; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine | 1992 |
Oral mesalamine for ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1992 |
[Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
Topics: Aminosalicylic Acids; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1992 |
Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis.
Topics: Administration, Oral; Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Colon; Cyclosporine; Female; Humans; Mesalamine; Methylprednisolone; Sulfasalazine | 1992 |
The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model.
Topics: Adenocarcinoma; Aminosalicylic Acids; Animals; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Incidence; Inflammatory Bowel Diseases; Male; Mesalamine; Metronidazole; Neoplasm Invasiveness; Rats; Rats, Wistar; Sulfasalazine | 1992 |
Colorectal cancer risk and mortality in patients with ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Child; Cohort Studies; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Mesalamine; Middle Aged; Risk; Sulfasalazine | 1992 |
Chronic intrajejunal TNBS application in TNBS-sensitized rats: a new model of chronic inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Animals; Disease Models, Animal; Female; Immunization; Inflammatory Bowel Diseases; Intestinal Mucosa; Jejunum; Mesalamine; Rats; Rats, Sprague-Dawley; Sulfasalazine; Trinitrobenzenesulfonic Acid | 1992 |
Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Calcimycin; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Imidazoles; Immunoglobulin E; Interleukin-1; Intestinal Mucosa; Mesalamine; Organ Culture Techniques; Platelet Activating Factor; Prednisolone; Sulfasalazine; Thiazoles | 1992 |
Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine.
Topics: Adult; Aminosalicylic Acids; Drug Hypersensitivity; Female; Humans; Liver; Mesalamine; Sulfasalazine | 1992 |
Sulphasalazine in ulcerative colitis.
Topics: Aminosalicylic Acids; Enterocolitis; Humans; Mesalamine; Radiotherapy; Sulfasalazine | 1992 |
Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.
Topics: Aminosalicylic Acids; Calcium; Cells, Cultured; Cytosol; Depression, Chemical; Granulocytes; Guanosine Triphosphate; Humans; Inositol 1,4,5-Trisphosphate; Mesalamine; Phosphatidic Acids; Phosphatidylinositols; Second Messenger Systems; Sulfapyridine; Sulfasalazine | 1992 |
Sequential histologic evaluations in collagenous colitis. Correlations with disease behavior and sampling strategy.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis; Collagen; Colon; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Prednisone; Sulfasalazine | 1992 |
[Serum cholinesterases as activity parameters in chronic inflammatory bowel diseases].
Topics: Acute-Phase Proteins; Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Cholinesterases; Colitis, Ulcerative; Crohn Disease; Female; Hematocrit; Humans; Male; Mesalamine; Middle Aged; Platelet Count; Recurrence; Retrospective Studies; Serum Albumin; Sulfasalazine | 1992 |
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
Topics: Aminosalicylic Acids; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; In Vitro Techniques; Luminescent Measurements; Mesalamine; Neutrophils; Spectrophotometry; Sulfasalazine; Superoxides; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines | 1991 |
[Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Topics: 6-Ketoprostaglandin F1 alpha; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chondrocalcinosis; Culture Techniques; Dinoprostone; Humans; Knee Joint; Leukotriene B4; Leukotrienes; Mesalamine; Osteoarthritis; Prostaglandins; SRS-A; Sulfapyridine; Sulfasalazine; Synovial Membrane | 1991 |
Lichen planus and mesalazine.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Lichen Planus; Male; Mesalamine; Middle Aged; Recurrence; Sulfasalazine | 1991 |
Mesalazine alveolitis.
Topics: Aged; Alveolitis, Extrinsic Allergic; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Male; Mesalamine; Sulfasalazine | 1991 |
Comment: mesalamine in ulcerative colitis.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Enema; Humans; Mesalamine; Sulfasalazine | 1991 |
Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocyte Membrane; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Lipid Peroxidation; Malondialdehyde; Mesalamine; Sulfasalazine | 1991 |
Modulation of arachidonic acid metabolism by olsalazine and other aminosalicylates in leukocytes.
Topics: Aminosalicylic Acids; Arachidonic Acid; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes, Mononuclear; Leukotrienes; Mesalamine; Neutrophils; Prostaglandins; Sulfasalazine | 1991 |
Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid.
Topics: Adult; Aged; Aminosalicylic Acids; Basophils; Cells, Cultured; Colon; Female; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Inflammatory Bowel Diseases; Male; Mast Cells; Mesalamine; Middle Aged; Prostaglandin D2; Sulfasalazine | 1991 |
Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
Topics: Aminosalicylic Acids; Arthritis, Rheumatoid; Cell Division; Endothelium, Vascular; Humans; Mesalamine; Middle Aged; Monocytes; Neovascularization, Pathologic; Sulfasalazine; Synovial Membrane | 1991 |
Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Drug Evaluation; Female; Humans; Life Tables; Male; Mesalamine; Middle Aged; Random Allocation; Recurrence; Remission Induction; Sulfasalazine | 1990 |
Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid.
Topics: Adult; Aged; Aminosalicylic Acids; Biopsy; Colitis, Ulcerative; Colonic Diseases, Functional; Crohn Disease; Feces; Female; Free Radicals; Humans; Lipid Peroxidation; Male; Mesalamine; Middle Aged; Oxidation-Reduction; Rectum; Sulfasalazine; Time Factors | 1990 |
Long-term use of mesalamine enemas to induce remission in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Therapy, Combination; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Prednisone; Recurrence; Remission Induction; Sulfasalazine | 1990 |
Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis.
Topics: Aminosalicylic Acids; Cells, Cultured; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Ionophores; Mesalamine; Platelet Activating Factor; Prednisolone; Sulfasalazine | 1990 |
Mesalazine: a global safety evaluation.
Topics: Aminosalicylic Acids; Crohn Disease; Dose-Response Relationship, Drug; Humans; Mesalamine; Sulfasalazine | 1990 |
Effect of 5-aminosalicylic acid on ferrous sulfate-mediated damage to deoxyribose.
Topics: Aminosalicylic Acids; Deoxyribose; Drug Interactions; Ferrous Compounds; Mesalamine; Pentetic Acid; Sulfapyridine; Sulfasalazine | 1990 |
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ)
Topics: Aminosalicylic Acids; Free Radicals; Humans; Mesalamine; Neutrophils; Sulfasalazine; Superoxides | 1990 |
Antiinflammatory effects of various drugs on acetic acid induced colitis in the rat.
Topics: Acetates; Acetic Acid; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Dexamethasone; Disease Models, Animal; Gossypol; Hydrocortisone; Indomethacin; Intestinal Mucosa; Leukocyte Count; Male; Masoprocol; Mesalamine; Neutrophils; Peroxidase; Rats; Rats, Inbred Strains; Sulfasalazine | 1990 |
Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.
Topics: Aminosalicylic Acids; Animals; Cold Temperature; Drug Combinations; Female; Mesalamine; Premedication; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological; Sulfapyridine; Sulfasalazine; Time Factors | 1990 |
[Cryptogenetic ulcerative colitis. Our clinical experience with new therapeutic approaches].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Female; Humans; Male; Mesalamine; Sulfasalazine | 1990 |
Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites.
Topics: Aminosalicylic Acids; Animals; Concanavalin A; Cyclosporins; Dose-Response Relationship, Drug; Female; Interleukin-2; Lymphocyte Activation; Mesalamine; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phytohemagglutinins; Sulfasalazine; T-Lymphocytes | 1990 |
Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; NADP; Prostaglandins E; Prostaglandins F; Sulfasalazine | 1990 |
Inhibition of antibody secretion by 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Antibodies; Cell Division; Cell Survival; Humans; Immunoglobulin A; Indomethacin; Intestinal Mucosa; Intestines; Mesalamine; Monocytes; Pokeweed Mitogens; Sulfapyridine; Sulfasalazine | 1989 |
Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Dapsone; Ileitis; Intestinal Absorption; Intestinal Mucosa; Mesalamine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine | 1989 |
Male infertility related to 5-ASA enemas.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Enema; Humans; Infertility, Male; Male; Mesalamine; Sulfasalazine | 1989 |
Sulphasalazine-induced reversible male infertility.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Follicle Stimulating Hormone; Humans; Infertility, Male; Luteinizing Hormone; Male; Mesalamine; Sperm Count; Sperm Motility; Sulfasalazine; Testosterone | 1989 |
Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease.
Topics: Acetylation; Aminosalicylic Acids; Chromatography, High Pressure Liquid; Colon; Feces; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Sulfasalazine | 1989 |
Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Aminosalicylic Acid; Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukocytes; Leukotriene B4; Lipoxygenase; Mesalamine; Prostaglandin-Endoperoxide Synthases; Sulfapyridine; Sulfasalazine; Zymosan | 1989 |
Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation.
Topics: Adult; Aminosalicylic Acids; Animals; Cricetinae; Female; Free Radicals; Humans; Infertility, Male; Inflammatory Bowel Diseases; Male; Mesalamine; Prospective Studies; Sperm-Ovum Interactions; Spermatozoa; Sulfasalazine; Superoxides | 1989 |
Active moiety of sulfasalazine.
Topics: Aminosalicylic Acids; Chemistry, Pharmaceutical; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1989 |
Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils.
Topics: Aminosalicylic Acids; Cell Separation; Humans; Luminescent Measurements; Luminol; Mesalamine; Neutrophils; Oxygen; Oxygen Consumption; Sulfasalazine; Superoxides | 1989 |
Pharmacokinetics of sulfasalazine metabolites in rats following concomitant oral administration of riboflavin.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Drug Interactions; Half-Life; Male; Mesalamine; Rats; Riboflavin; Sulfapyridine; Sulfasalazine | 1989 |
Mesalazine in childhood inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Sulfasalazine | 1989 |
Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Biological Transport; Bradykinin; Colitis, Ulcerative; Crohn Disease; Diarrhea; Disease Models, Animal; Electrolytes; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Intestinal Diseases; Lipoxygenase; Mesalamine; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Sulfapyridine; Sulfasalazine | 1985 |
Disposition of disodium azodisalicylate in healthy subjects. A possible new drug for inflammatory bowel disease.
Topics: Administration, Oral; Aminosalicylic Acids; Crohn Disease; Half-Life; Humans; Kinetics; Mesalamine; Sulfapyridine; Sulfasalazine | 1985 |
Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
Topics: Aminosalicylic Acids; Animals; Arachidonic Acid; Arachidonic Acids; Colon; Cytosol; Glutathione; Intestinal Mucosa; Mesalamine; Microsomes; Prostaglandins; Rabbits; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1985 |
A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.
Topics: Aminosalicylic Acids; Animals; Chemical Phenomena; Chemistry; Colitis; Free Radicals; Humans; Indomethacin; Mesalamine; Rats; Sulfasalazine; Superoxides | 1985 |
Pure-red-cell aplasia associated with sulphasalazine but not 5-aminosalicylic acid.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Female; Humans; Mesalamine; Sulfasalazine | 1985 |
Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
Topics: Aminosalicylic Acids; Catechols; Cytotoxicity, Immunologic; Humans; In Vitro Techniques; Indomethacin; Killer Cells, Natural; Lipoxygenase Inhibitors; Masoprocol; Mesalamine; Monocytes; Sulfapyridine; Sulfasalazine | 1985 |
Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Autoradiography; Chromatography, Thin Layer; Colitis, Ulcerative; Colon; Humans; In Vitro Techniques; Intestinal Mucosa; Lipoxygenase; Mesalamine; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sulfapyridine; Sulfasalazine; Thromboxane B2 | 1985 |
Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis.
Topics: Aminosalicylic Acids; Animals; Cells, Cultured; Colon; Fatty Acids; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Nitrites; Oxidation-Reduction; Rats; Salicylates; Structure-Activity Relationship; Sulfapyridine; Sulfasalazine | 1986 |
Determination of the pK values of 5-aminosalicylic acid and N-acetylaminosalicylic acid and comparison of the pH dependent lipid-water partition coefficients of sulphasalazine and its metabolites.
Topics: Aminosalicylic Acids; Chemical Phenomena; Chemistry, Physical; Hydrogen-Ion Concentration; Mesalamine; Sulfasalazine | 1985 |
Effect of azodisal sodium on the distribution of a transit marker in the small bowel of the fasted rat.
Topics: Aminosalicylic Acids; Animals; Gastrointestinal Motility; Intestine, Small; Male; Mesalamine; Prostaglandins; Rats; Rats, Inbred Strains; Sulfasalazine; Time Factors | 1986 |
The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Drug Hypersensitivity; Humans; Mesalamine; Sulfasalazine; Tablets, Enteric-Coated | 1985 |
[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Topics: Adolescent; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Mesalamine; Sulfasalazine | 1986 |
Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.
Topics: Aminosalicylic Acids; Animals; Cytotoxicity, Immunologic; Humans; In Vitro Techniques; Killer Cells, Natural; Killer Factors, Yeast; Mesalamine; Mice; Proteins; Sulfanilamides; Sulfapyridine; Sulfasalazine; Time Factors | 1986 |
A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
Topics: Adult; Aged; Aminosalicylic Acids; Arthritis, Rheumatoid; Female; Humans; Male; Mesalamine; Middle Aged; Nausea; Sulfapyridine; Sulfasalazine | 1986 |
Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Kinetics; Male; Mesalamine; Middle Aged; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1986 |
Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Mucosa; Kinetics; Leukotriene E4; Mesalamine; Rectum; Reference Values; SRS-A; Sulfasalazine | 1986 |
[Crohn disease in childhood].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Child; Combined Modality Therapy; Crohn Disease; Cross-Sectional Studies; Diseases in Twins; Epithelium; Humans; Intestinal Mucosa; Mesalamine; Risk; Sulfasalazine | 1986 |
Sulphasalazine in inflammatory bowel disease: recent advances.
Topics: Administration, Oral; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Male; Mesalamine; Middle Aged; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1986 |
Keratoconjunctivitis sicca and the treatment of canine colitis.
Topics: Aminosalicylic Acids; Animals; Colitis; Dog Diseases; Dogs; Female; Keratoconjunctivitis; Keratoconjunctivitis Sicca; Male; Mesalamine; Sulfasalazine | 1986 |
Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
Topics: Adult; Aminosalicylic Acids; Antioxidants; Cell-Free System; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Luminescent Measurements; Mesalamine; Neutrophils; Sulfapyridine; Sulfasalazine; Superoxides; Xanthine Oxidase; Xanthines; Zymosan | 1987 |
Simple and sensitive high-performance liquid chromatographic assay for 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in serum.
Topics: Aminosalicylic Acids; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Humans; Mesalamine; Sulfasalazine | 1987 |
Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
Topics: Aminosalicylic Acids; Animals; Cell Division; Colon; Deoxycholic Acid; DNA; Epithelium; Female; Free Radicals; Mesalamine; Ornithine Decarboxylase; Oxygen; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine; Superoxide Dismutase; Thymidine; Xanthine; Xanthines | 1987 |
[Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
Topics: Administration, Oral; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Enema; Humans; Mesalamine; Sulfasalazine | 1987 |
Sulphasalazine: drug or pro-drug?
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Male; Mesalamine; Sulfasalazine | 1987 |
[5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
Topics: Acute Disease; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Combinations; Drug Eruptions; Drug Hypersensitivity; Drug Tolerance; Female; Glucosamine; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1987 |
[Salazosulfapyridine or 5-aminosalicylic acid].
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Enema; Humans; Mesalamine; Sulfasalazine; Suppositories | 1987 |
Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Free Radicals; Humans; Luminescent Measurements; Mesalamine; Neutrophils; Oxygen; Sulfapyridine; Sulfasalazine | 1987 |
[Salazosulfapyridine or 5-aminosalicylic acid].
Topics: Aminosalicylic Acids; Drug Evaluation; Humans; Mesalamine; Sulfasalazine | 1987 |
Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon i
Topics: Aminosalicylic Acids; Animals; Colitis, Ulcerative; Colon; Ileum; Intestinal Absorption; Intestinal Mucosa; Mesalamine; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine | 1987 |
Favorable effects of sulfasalazine on small bowel Crohn's disease: a long-term study.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Crohn Disease; Female; Humans; Intestine, Small; Male; Mesalamine; Middle Aged; Sulfasalazine | 1987 |
Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
Topics: Aminosalicylic Acids; Antigen-Antibody Complex; Exocytosis; Humans; Mesalamine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Sulfapyridine; Sulfasalazine; Superoxides | 1987 |
Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
Topics: Adult; Aminosalicylic Acids; Bronchiolitis Obliterans; Colitis, Ulcerative; Desensitization, Immunologic; Humans; Male; Mesalamine; Pulmonary Eosinophilia; Pulmonary Fibrosis; Sulfasalazine | 1987 |
[Salazosulfapyridine or 5-aminosalicylic acid].
Topics: Aminosalicylic Acids; Colon; Humans; Mesalamine; Sulfasalazine | 1987 |
Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Colon; Crohn Disease; Dinoprostone; Humans; In Vitro Techniques; Intestinal Mucosa; Leukotriene B4; Mesalamine; Peptide Biosynthesis; Prostaglandins E; Sulfasalazine | 1987 |
The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.
Topics: Aminosalicylic Acids; Animals; Dinoprostone; Ethanol; Female; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrointestinal Motility; Mesalamine; Mucus; Pepsin A; Prostaglandins E; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulfasalazine | 1987 |
Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Infertility, Male; Male; Mesalamine; Oligospermia; Sperm Count; Sperm Motility; Spermatozoa; Sulfasalazine | 1987 |
Sulfasalazine and its anti-inflammatory metabolite, 5-aminosalicylic acid: effect on arachidonic acid metabolism in human neutrophils, and free radical scavenging.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Biphenyl Compounds; Free Radicals; Humans; Hydrazines; In Vitro Techniques; Intestinal Diseases; Lipoxygenase Inhibitors; Mesalamine; Neutrophils; Picrates; Sulfasalazine | 1987 |
The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Hydroxides; Hydroxyl Radical; Hypochlorous Acid; Mesalamine; Oxidation-Reduction; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1987 |
Role of the intestinal flora in the acetylation of sulfasalazine metabolites.
Topics: Acetylation; Aminosalicylic Acids; Animals; Guinea Pigs; Intestines; Male; Mesalamine; Rats; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1987 |
Possible mode of action of 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Intestinal Mucosa; Leukotriene B4; Leukotriene E4; Mesalamine; Rectum; SRS-A; Sulfasalazine | 1987 |
Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid.
Topics: Adult; Aminosalicylic Acids; Body Fluids; Female; Fetus; Humans; Maternal-Fetal Exchange; Mesalamine; Middle Aged; Pregnancy; Sulfasalazine | 1987 |
Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Enema; Female; Humans; Infant, Newborn; Infertility, Male; Male; Mesalamine; Pregnancy; Sperm-Ovum Interactions; Sulfasalazine | 1988 |
5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat.
Topics: Aminosalicylic Acids; Animals; Dimethyl Sulfoxide; Gastrointestinal Hemorrhage; Hydroxides; Hydroxyl Radical; Ischemia; Male; Mesalamine; Rats; Rats, Inbred Strains; Stomach; Stomach Diseases; Sulfasalazine | 1988 |
Pentasa in lieu of sulfasalazine.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Middle Aged; Sulfasalazine | 1988 |
Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
Topics: Aminosalicylic Acids; Animals; Calcimycin; Cell Separation; Mesalamine; Muscle Contraction; Muscle, Smooth; Peritoneal Cavity; Rats; Rats, Inbred Strains; SRS-A; Sulfapyridine; Sulfasalazine | 1988 |
In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief report.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Enterobacteriaceae; Gram-Negative Bacteria; Mesalamine; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1988 |
Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
Topics: Aminosalicylic Acids; Arthritis, Rheumatoid; Cell Survival; Female; Humans; Lectins; Leukocyte Count; Leukocytes, Mononuclear; Lymphocytes; Male; Mesalamine; Sulfapyridine; Sulfasalazine; Thymidine | 1988 |
In vitro immunomodulatory effects of sulfasalazine and its metabolites.
Topics: Aminosalicylic Acids; Arthritis, Rheumatoid; Cell Division; Cells, Cultured; Humans; Immune System; Immunoglobulin M; Immunoglobulins; Mesalamine; Rheumatoid Factor; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1988 |
Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action?
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Female; Lymphocyte Activation; Mesalamine; Mice; Mice, Inbred CBA; Mitogens; Sulfapyridine; Sulfasalazine | 1988 |
Sulfasalazine-induced abnormal sperm penetration.
Topics: Aminosalicylic Acids; Female; Humans; Infertility, Male; Male; Mesalamine; Sperm-Ovum Interactions; Sulfasalazine | 1988 |
Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Female; Humans; Male; Mesalamine; Sulfasalazine | 1988 |
Adverse effects with oral 5-aminosalicyclic acid.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Desensitization, Immunologic; Drug Hypersensitivity; Drug Tolerance; Humans; Male; Mesalamine; Middle Aged; Sulfapyridine; Sulfasalazine | 1988 |
[Acute manifestations in Crohn disease and ulcerative colitis. Conservative treatment of acute situations].
Topics: Acute Disease; Aminosalicylic Acids; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Humans; Mesalamine; Parenteral Nutrition; Prednisone; Prospective Studies; Sulfasalazine | 1988 |
Adverse reactions to sulphasalazine and 5-amino salicylic acid in the same patient.
Topics: Adult; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Humans; Male; Mesalamine; Sulfasalazine | 1987 |
Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Chemotaxis; Female; Humans; In Vitro Techniques; Intestinal Mucosa; Leukotriene B4; Macrophages; Male; Mesalamine; Middle Aged; Sulfasalazine | 1988 |
5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?
Topics: Aminosalicylic Acids; Colon; Depression, Chemical; Epoprostenol; Humans; Mesalamine; Prostaglandins; Sulfasalazine | 1981 |
Inhibition of leucocyte motility by drugs used in ulcerative colitis.
Topics: Aminosalicylic Acids; Cell Movement; Chemotaxis, Leukocyte; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Indomethacin; Leukocytes; Mesalamine; Prednisolone; Sulfapyridine; Sulfasalazine | 1981 |
Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.
Topics: Aminosalicylic Acids; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Reference Values; Sulfasalazine | 1981 |
Increased suppressor cell activity in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Hydrocortisone; In Vitro Techniques; Indomethacin; Lymphocyte Activation; Mesalamine; Mitogens; Sulfapyridine; Sulfasalazine; T-Lymphocytes, Regulatory | 1981 |
Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Calcimycin; Dose-Response Relationship, Drug; Humans; Hydroxyeicosatetraenoic Acids; Indomethacin; Leukotriene B4; Mesalamine; Neutrophils; Sulfasalazine | 1982 |
[5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine; Suppositories | 1982 |
Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
Topics: Aminosalicylic Acids; Concanavalin A; Crohn Disease; Humans; Lymphocyte Activation; Mesalamine; Sulfapyridine; Sulfasalazine; T-Lymphocytes, Regulatory | 1982 |
Will there be a next generation of sulfasalazine?
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Guinea Pigs; Humans; Mesalamine; Rats; Sulfasalazine | 1982 |
Inhibition of prostaglandin synthetase in human rectal mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Flurbiprofen; Humans; Indomethacin; Intestinal Mucosa; Mesalamine; Prednisolone; Rectum; Sulfapyridine; Sulfasalazine | 1983 |
Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Glycine max; Humans; Kinetics; Lipoxygenase Inhibitors; Mesalamine; Sulfasalazine | 1983 |
Inhibition of platelet thromboxane synthetase by sulfasalazine.
Topics: Aminosalicylic Acids; Arachidonate Lipoxygenases; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Intestinal Mucosa; Lipoxygenase Inhibitors; Mesalamine; Neutrophils; Oxidoreductases; Sulfasalazine; Thromboxane B2; Thromboxane-A Synthase | 1983 |
A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma.
Topics: Aminosalicylic Acids; Chromatography, High Pressure Liquid; Humans; Mesalamine; Sulfanilamides; Sulfapyridine; Sulfasalazine; Time Factors | 1983 |
Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1983 |
Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine.
Topics: Aminosalicylic Acids; Bacteria; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Kinetics; Mesalamine; Prostaglandins; Sulfapyridine; Sulfasalazine | 1983 |
5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine.
Topics: Acute Disease; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1984 |
Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Intestinal Absorption; Male; Mesalamine; Middle Aged; Sulfasalazine; Tablets, Enteric-Coated; Time Factors | 1984 |
Reversal with balsalazide of infertility caused by sulphsalazine.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Infertility, Male; Male; Mesalamine; Phenylhydrazines; Sperm Count; Sulfasalazine | 1984 |
Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Infertility, Male; Male; Mesalamine; Sulfasalazine | 1984 |
Sulphasalazine-induced infertility reversed on transfer to 5-aminosalicylic acid.
Topics: Adult; Aminosalicylic Acids; Delayed-Action Preparations; Humans; Infertility, Male; Male; Mesalamine; Proctocolitis; Sulfasalazine | 1984 |
The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs.
Topics: Aminosalicylic Acids; Animals; Carrageenan; Cecum; Colitis; Delayed-Action Preparations; Drug Evaluation, Preclinical; Guinea Pigs; Intestinal Mucosa; Mesalamine; Sulfasalazine | 1984 |
Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Antigens; Arthritis, Rheumatoid; Cholera Toxin; Female; Humans; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Inflammatory Bowel Diseases; Injections, Subcutaneous; Intestinal Mucosa; Mesalamine; Mice; Mice, Inbred C57BL; Sulfapyridine; Sulfasalazine | 1995 |
Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion Molecules; Cells, Cultured; Colitis, Ulcerative; Colon; Crohn Disease; Culture Media, Conditioned; E-Selectin; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; Mesalamine; Middle Aged; Sulfasalazine; Umbilical Veins; Up-Regulation | 1995 |
Ischemia reperfusion damage in the gut and its treatment with drugs of the aminosalicylic acid group.
Topics: Aminosalicylic Acids; Animals; Benzaldehydes; Glutathione; Glutathione Disulfide; Hydrazones; Intestinal Mucosa; Intestines; Male; Mesalamine; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Sulfasalazine; Thiobarbituric Acid Reactive Substances | 1994 |
Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binding, Competitive; Drug Interactions; Gallic Acid; Humans; Kinetics; Mercaptopurine; Mesalamine; Methylation; Methyltransferases; Pyridines; Recombinant Proteins; Substrate Specificity; Sulfapyridine; Sulfasalazine | 1995 |
[Discussion apropos of a case of ulcerative colitis].
Topics: Adrenal Cortex Hormones; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Mesalamine; Prognosis; Sulfasalazine | 1995 |
[5-ASA versus sulfasalazine].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 1994 |
5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
Topics: Aminosalicylic Acids; Calcium; Cell Survival; Gene Expression; Humans; In Vitro Techniques; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Mesalamine; Receptors, Interleukin-2; RNA, Messenger; Sulfapyridine; Sulfasalazine; T-Lymphocytes | 1995 |
[Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Topics: Aminosalicylic Acids; Chronic Disease; Colitis; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methylprednisolone; Recurrence; Sulfasalazine | 1995 |
Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease.
Topics: Acute Disease; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Humans; Mesalamine; Pancreatitis; Sulfasalazine | 1994 |
[Is preventive drug therapy of recurrent Crohn disease indicated after ileocecal resection?].
Topics: Aminosalicylic Acids; Cecum; Combined Modality Therapy; Crohn Disease; Humans; Ileum; Mesalamine; Recurrence; Sulfasalazine | 1994 |
Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Biopharmaceutics; Biotransformation; Chemical Phenomena; Chemistry, Physical; Colon; Drug Design; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Mesalamine; Prodrugs; Rats; Rats, Wistar; Solubility; Sulfanilic Acids; Sulfasalazine | 1994 |
Is maintenance therapy effective in Crohn's disease?
Topics: Aminosalicylic Acids; Crohn Disease; Humans; Mesalamine; Meta-Analysis as Topic; Prednisone; Recurrence; Sulfasalazine | 1994 |
Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Crohn Disease; Humans; Ileitis; Mesalamine; Recurrence; Sulfasalazine | 1994 |
Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.
Topics: Aminopeptidases; Aminosalicylic Acids; Animals; Carboxypeptidases; Chromatography, High Pressure Liquid; Colostomy; Glutamyl Aminopeptidase; Intestinal Absorption; Male; Mesalamine; Microvilli; Prodrugs; Rats; Rats, Inbred Strains; Sulfasalazine | 1994 |
Urinary growth hormone in growth-impaired children with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Creatinine; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Failure to Thrive; Female; Growth Disorders; Growth Hormone; Humans; Male; Mesalamine; Prednisolone; Sulfasalazine | 1993 |
[Localization of salazopyrin in colonic mucosa patients with ulcerative colitis].
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Colon; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Sulfasalazine | 1993 |
Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antibody-Dependent Cell Cytotoxicity; Autoantibodies; Colitis, Ulcerative; Colon; Cytotoxicity Tests, Immunologic; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interferon-gamma; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Male; Mesalamine; Middle Aged; Prednisolone; Sulfasalazine | 1993 |
Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
Topics: Aminosalicylic Acids; Calcium; Free Radical Scavengers; Free Radicals; Humans; In Vitro Techniques; Mesalamine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Sulfapyridine; Sulfasalazine; Superoxides; Tetradecanoylphorbol Acetate | 1993 |
Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children.
Topics: Aminosalicylic Acids; Biological Availability; Child; Delayed-Action Preparations; Feces; Female; Humans; Male; Mesalamine; Sulfasalazine | 1993 |
Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Biopsy; Calcium; Cells, Cultured; Dinoprostone; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intracellular Fluid; Leukotriene B4; Male; Mesalamine; Radioimmunoassay; Steroids; Sulfasalazine | 1995 |
Maintenance strategies in Crohn's disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Diagnosis, Differential; Female; Humans; Male; Mesalamine; Postoperative Care; Remission Induction; Sulfasalazine | 1996 |
Cutaneous hypersensitivity reaction to mesalazine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Humans; Male; Mesalamine; Sulfasalazine | 1996 |
Clinical outcome of ulcerative colitis in children.
Topics: Adolescent; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Infant; Male; Mesalamine; Sulfasalazine; Treatment Outcome | 1996 |
Drug induced otalgia due to mesalazine and sulphasalazine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Earache; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1996 |
Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Enzyme Tests; Enzymes; Female; Humans; Inflammatory Bowel Diseases; Kidney Diseases; Kidney Tubules; Male; Mesalamine; Middle Aged; Sulfasalazine | 1996 |
Prescriptions for mesalazine and sulphasalazine: a prevalence estimate of patients treated for inflammatory bowel disease in Rome.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Drug Utilization; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Italy; Mesalamine; Prevalence; Sulfasalazine | 1996 |
Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine an anti-inflammatory medicine.
Topics: Aminosalicylic Acids; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bone Marrow; Carcinogenicity Tests; DNA Adducts; Female; Folic Acid; Liver; Male; Mesalamine; Mice; Micronuclei, Chromosome-Defective; Mutagenicity Tests; Rats; Rats, Sprague-Dawley; Risk Assessment; Sulfapyridine; Sulfasalazine; Urinary Bladder | 1997 |
[Hypersensitivity to 5-aminosalicylic acid. Value of desensitization by oral route].
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Child; Crohn Disease; Desensitization, Immunologic; Drug Hypersensitivity; Female; Gastrointestinal Agents; Humans; Mesalamine; Sulfasalazine | 1997 |
5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Gastrointestinal Agents; Hospitalization; Humans; Male; Medical Records; Mesalamine; Middle Aged; Prednisolone; Retrospective Studies; Sulfasalazine; Treatment Outcome; United Kingdom | 1997 |
[Current medical therapies for Crohn's disease in Japan].
Topics: Aminosalicylic Acids; Crohn Disease; Food, Fortified; Gastrointestinal Agents; Humans; Japan; Mesalamine; Metronidazole; Prednisone; Sulfasalazine | 1997 |
[Pharmacological studies of BX661A. 5-[4-(2-carboxyethylcarbamoyl)-phenylazo]-salicylic acid disodium salt dihydrate (1). Therapeutic effects on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) model in rats].
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Dextran Sulfate; Male; Mesalamine; Phenylhydrazines; Rats; Rats, Sprague-Dawley; Sulfapyridine; Sulfasalazine | 1997 |
An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
Topics: Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Betamethasone; Bronchoalveolar Lavage Fluid; Colitis, Ulcerative; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Immunity, Cellular; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisolone; Sulfasalazine | 1997 |
Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line; Epithelial Cells; Humans; Intestines; Mesalamine; Nitrates; Nitric Oxide; Sulfasalazine | 1997 |
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blotting, Western; Cells, Cultured; Colonic Diseases; Cystine; Epithelial Cells; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppression Therapy; Lipopolysaccharides; Mesalamine; NF-kappa B; Phorbol Esters; Phosphorylation; Plasmids; Proline; Recombinant Proteins; Recombination, Genetic; Sulfapyridine; Sulfasalazine; Thiocarbamates; Transcription Factor AP-1; Transfection; Tumor Necrosis Factor-alpha | 1998 |
[Collagenous colitis: presentation of 12 cases].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Biopsy; Ciprofloxacin; Colitis; Colon; Erythromycin; Female; Gastrointestinal Agents; Humans; Loperamide; Male; Mesalamine; Middle Aged; Parasympatholytics; Phenethylamines; Prednisone; Quaternary Ammonium Compounds; Sulfasalazine | 1997 |
[Follow-up observation of intestinal Behçet disease treated with salazosulfapyridine and mesalazine for 8 years and 9 months].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Follow-Up Studies; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine; Time Factors | 1998 |
Efficacy of treatment for ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1998 |
[Vulvar Crohn disease: 3 cases].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Crohn Disease; Female; Humans; Mesalamine; Middle Aged; Skin Ulcer; Sulfasalazine; Treatment Outcome; Vulvar Diseases | 1997 |
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Topics: Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; Cytochrome c Group; Hydrogen Peroxide; Hypochlorous Acid; Kinetics; Mesalamine; Phenylhydrazines; Reactive Oxygen Species; Sulfapyridine; Sulfasalazine; Superoxides | 1998 |
Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
Topics: Alanine; Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Colitis, Ulcerative; Colon; Dextran Sulfate; Drug Interactions; Male; Mesalamine; Phenylhydrazines; Rats; Rats, Sprague-Dawley; Sulfapyridine; Sulfasalazine | 1998 |
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Topics: Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Chemotaxis, Leukocyte; Colitis, Ulcerative; Guinea Pigs; Humans; In Vitro Techniques; Male; Mesalamine; Neutrophils; Phenylhydrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sulfapyridine; Sulfasalazine | 1998 |
Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Topics: Adenomatous Polyps; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Fluorometry; Intestinal Neoplasms; Mesalamine; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Piroxicam; Sulfasalazine; Sulindac | 1999 |
Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biocompatible Materials; Cell Division; Chemokine CCL2; Chemotaxis; Collagen; Drug Combinations; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-8; Laminin; Mesalamine; Proteoglycans; Solubility; Sulfapyridine; Sulfasalazine | 1999 |
Endoscopic and histological patchiness in treated ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Chi-Square Distribution; Colitis, Ulcerative; Colonoscopy; Eosinophils; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Mucosa; Male; Mesalamine; Metaplasia; Middle Aged; Neutrophils; Plasma Cells; Prevalence; Rectum; Retrospective Studies; Sigmoidoscopy; Steroids; Sulfasalazine | 1999 |
Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chitin; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Carriers; Male; Mesalamine; Models, Biological; Rats; Rats, Wistar; Reproducibility of Results; Sulfasalazine; Trinitrobenzenesulfonic Acid | 1999 |
Ultrasonography in the evaluation of extension, activity, and follow-up of ulcerative colitis.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Barium Sulfate; Blood Sedimentation; C-Reactive Protein; Child; Colitis, Ulcerative; Drug Combinations; Enema; Female; Glucocorticoids; Glucosamine; Humans; Male; Mesalamine; Methylprednisolone; Middle Aged; Sigmoidoscopy; Sulfasalazine; Ultrasonography | 1999 |
Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Kinetics; Mesalamine; Mice; Mice, Inbred C57BL; NF-kappa B; Sulfapyridine; Sulfasalazine; T-Lymphocytes; Transcriptional Activation; Tumor Cells, Cultured | 1999 |
Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
Topics: Arthritis, Rheumatoid; Cells, Cultured; Cytokines; Fibroblasts; Homeostasis; Humans; Inflammation Mediators; Matrix Metalloproteinases; Mesalamine; Osmolar Concentration; RNA, Messenger; Sulfapyridine; Sulfasalazine; Synovial Membrane; Tissue Inhibitor of Metalloproteinases | 2000 |
Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Digestive System; Drug Stability; Feces; Hippurates; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Mesalamine; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfasalazine | 2000 |
Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat.
Topics: Acute Disease; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Aza Compounds; Chronic Disease; Colitis; Colon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastrointestinal Agents; Intestinal Mucosa; Intestines; Male; Mesalamine; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2000 |
[Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Enema; Eosinophilia; Female; Gastrointestinal Agents; Humans; Legionella pneumophila; Legionnaires' Disease; Lung; Mesalamine; Sulfasalazine | 2000 |
Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Topics: Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport, Active; Caco-2 Cells; Carrier Proteins; Cell Membrane Permeability; Cold Temperature; Energy Metabolism; Gastrointestinal Agents; Humans; Intestinal Absorption; Kinetics; Mesalamine; Multidrug Resistance-Associated Proteins; Structure-Activity Relationship; Sulfapyridine; Sulfasalazine | 2000 |
Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Kidney Diseases; Kidney Function Tests; Male; Mesalamine; Middle Aged; Retrospective Studies; Single-Blind Method; Sulfasalazine; Survivors | 2000 |
Progress in understanding the mechanisms of action of 5-aminosalicylic acid.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; NF-kappa B; Sulfasalazine | 2000 |
[Hypersensitivity to mesalazine after severe allergic reaction to sulfasalazine].
Topics: Adult; Drug Hypersensitivity; Female; Humans; Male; Mesalamine; Sulfasalazine | 2001 |
In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Topics: Animals; Arachidonate 5-Lipoxygenase; Benzothiazoles; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Humans; Hydroxyurea; Indomethacin; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mesalamine; Methacrylates; Neutrophils; Peritoneal Cavity; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Inbred F344; Sheep; Sulfasalazine; Thiazoles; Thromboxane B2; Thromboxane-A Synthase | 2001 |
Glucocorticoids and IL-10, but not 6-MP, 5-ASA or sulfasalazine block endothelial expression of MAdCAM-1: implications for inflammatory bowel disease therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion Molecules; Cells, Cultured; Dexamethasone; Endothelium; Glucocorticoids; Immunoglobulins; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Lymphocytes; Mercaptopurine; Mesalamine; Mice; Mucoproteins; Reverse Transcriptase Polymerase Chain Reaction; Sulfasalazine; Thymidine Kinase; Tumor Necrosis Factor-alpha | 2001 |
Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Sulfasalazine; Treatment Outcome | 2001 |
Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Histocompatibility Antigens Class II; Interferon-gamma; Interleukin-12; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mesalamine; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Sulfapyridine; Sulfasalazine; Up-Regulation | 2001 |
5-Aminosalicylate stimulates phospholipase D activity in macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Cells, Cultured; Ceramides; Dose-Response Relationship, Drug; Enzyme Activation; Female; Macrophages, Peritoneal; Mesalamine; Mice; Models, Chemical; Phospholipase D; Protein Kinase C; Signal Transduction; Sphingomyelins; Sulfasalazine; Time Factors; Tritium | 2001 |
[Collagenous colitis. A study of 11 cases].
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Azathioprine; Chronic Disease; Colitis; Collagen; Colonoscopy; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Mixed Connective Tissue Disease; Retrospective Studies; Serum Albumin; Spondylitis; Steroids; Sulfasalazine; Thyroiditis, Autoimmune; Treatment Outcome | 2001 |
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
Topics: Adult; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binomial Distribution; Chromatography, High Pressure Liquid; Confidence Intervals; Drug Interactions; Female; Humans; Immunosuppressive Agents; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Sulfasalazine; Thioguanine | 2001 |
[A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Child; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Mesalamine; Retrospective Studies; Sulfasalazine | 2001 |
Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Diarrhea; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Sulfasalazine | 2002 |
Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Desensitization, Immunologic; Dyspepsia; Follow-Up Studies; Headache; Humans; Infertility, Male; Male; Mesalamine; Sulfasalazine | 2001 |
Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers.
Topics: Absorption; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Enema; Humans; Male; Mesalamine; Sulfasalazine; Suppositories | 2002 |
[Pancreatic involvement in inflammatory bowel diseases in children].
Topics: Adolescent; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Pancreatitis; Retrospective Studies; Sulfasalazine | 2002 |
N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arylamine N-Acetyltransferase; Child; Colitis, Ulcerative; Female; Genotype; Humans; Isoenzymes; Male; Mesalamine; Middle Aged; Sulfasalazine | 2002 |
The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Chemokine CCL2; Chemokine CXCL1; Chemokines; Chemokines, CXC; Chemotactic Factors; Culture Media, Conditioned; Female; Fibroblasts; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-1; Interleukin-8; Male; Mesalamine; Middle Aged; Sulfapyridine; Sulfasalazine; Synovial Membrane | 2002 |
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Drug Eruptions; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mesalamine; Nephritis, Interstitial; Pancreatitis; Paraproteinemias; Sulfasalazine | 2002 |
Which 5-ASA?
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Enema; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine; Suppositories | 2002 |
Butyrate modulates intestinal epithelial cell-mediated neutrophil migration.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Caco-2 Cells; Chemotaxis, Leukocyte; HT29 Cells; Humans; Interleukin-1; Interleukin-8; Intestinal Mucosa; Mesalamine; Receptors, Interleukin-1; RNA, Messenger; Sulfasalazine; Transcription, Genetic | 2003 |
[Crohn's disease in children].
Topics: Child; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 2002 |
The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
Topics: Amino Acids; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Desulfovibrio; Feces; Fermentation; Fusobacterium; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Mesalamine; Phenylhydrazines; Sulfasalazine; Sulfides | 2003 |
Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa.
Topics: Administration, Oral; Adult; Aged; Colitis, Ulcerative; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Prednisone; Rectum; Severity of Illness Index; Sulfasalazine; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Which 5-ASA?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases, Functional; Humans; Mesalamine; Sulfasalazine | 2003 |
Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
Topics: Adult; Arylamine N-Acetyltransferase; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Kidney Diseases; Leukopenia; Male; Mesalamine; Polymerase Chain Reaction; Polymorphism, Genetic; Sulfapyridine; Sulfasalazine | 2003 |
How safe are the safest IBD drugs?
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mesalamine; Nephritis, Interstitial; Pancreatitis; Sulfasalazine | 2003 |
Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.
Topics: Adult; Aged; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Caenorhabditis elegans; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Sulfasalazine | 2003 |
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Data Interpretation, Statistical; Databases, Factual; Humans; Kidney Diseases; Mesalamine; Sulfasalazine | 2003 |
Mesalazine is safe for the treatment of IBD.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 2004 |
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Topics: Adolescent; Adult; Case-Control Studies; Child; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Cytoprotection; Female; Humans; Male; Mesalamine; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Severity of Illness Index; Smoking; Sulfasalazine | 2004 |
Clinical features and management of Crohn's disease in Chinese patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Male; Mesalamine; Middle Aged; Prednisone; Sulfasalazine; Ultrasonography | 2004 |
Susceptibility of Desulfovibrio desulfuricans intestinal strains to sulfasalazine and its biotransformation products.
Topics: Biotransformation; Cell Division; Desulfovibrio desulfuricans; Drug Resistance, Bacterial; Humans; Intestines; Mesalamine; Sulfapyridine; Sulfasalazine | 2004 |
Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cells, Cultured; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Humans; Immunity, Mucosal; Intestinal Mucosa; Jurkat Cells; Lymphocyte Activation; Mesalamine; Sulfapyridine; Sulfasalazine; T-Lymphocytes | 2004 |
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Diarrhea; Disease Models, Animal; Gastrointestinal Agents; Ileum; Mesalamine; Phenylhydrazines; Prodrugs; Rabbits; Random Allocation; Sulfasalazine; Tissue Culture Techniques | 2005 |
[Chronic inflammatory bowel diseases. Update on evidence-based therapy].
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Quality of Life; Sulfasalazine; Time Factors | 2005 |
The case for using 5-aminosalicyclates in Crohn's disease: pro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Meta-Analysis as Topic; Sulfasalazine; Treatment Outcome | 2005 |
Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity.
Topics: Aminosalicylic Acids; Anions; Antioxidants; Electrons; Free Radical Scavengers; Free Radicals; Glutathione; Hydrogen-Ion Concentration; Hydroxyl Radical; Inflammation; Inflammatory Bowel Diseases; Kinetics; Lipid Peroxidation; Mesalamine; Models, Chemical; Oxygen; Peroxides; Pulse Radiolysis; Spectrophotometry; Sulfapyridine; Sulfasalazine; Time Factors | 2005 |
Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL20; Chemokines, CC; Colitis, Ulcerative; Dexamethasone; Down-Regulation; Female; Glucocorticoids; Humans; Immunohistochemistry; Leukocytes, Mononuclear; Macrophage Inflammatory Proteins; Male; Mesalamine; Sulfasalazine; Tumor Necrosis Factor-alpha | 2005 |
Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Depression, Chemical; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Glycochenodeoxycholic Acid; Hepatocytes; Humans; Liver; Male; Mesalamine; NF-kappa B; Perfusion; Rats; Rats, Sprague-Dawley; Sulfapyridine; Sulfasalazine | 2006 |
Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Colitis; Colon; Drug Delivery Systems; Feces; Gastrointestinal Agents; Intestinal Absorption; Male; Mesalamine; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfasalazine; Taurine; Trinitrobenzenesulfonic Acid | 2006 |
Collagenous colitis and spondylarthropathy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Collagenous; Drug Therapy, Combination; Female; Humans; Male; Mesalamine; Middle Aged; Prednisolone; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Mesalamine may be preferable to sulfasalazine in dermatologic therapeutics.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Lichen Planus; Mesalamine; Sulfasalazine; Treatment Outcome | 2006 |
Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid.
Topics: Colitis, Ulcerative; Dermatitis, Exfoliative; Exanthema; Humans; Male; Mesalamine; Stevens-Johnson Syndrome; Sulfasalazine | 2006 |
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colorectal Neoplasms; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Risk; Sulfasalazine; United States | 2007 |
Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Topics: Adult; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; Denmark; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Mesalamine; Minnesota; Population Surveillance; Precancerous Conditions; Prognosis; Risk Factors; Sulfasalazine | 2007 |
[Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Humans; Lung Diseases; Male; Mesalamine; Radiography; Sulfasalazine | 2006 |
Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Confidence Intervals; Congenital Abnormalities; Crohn Disease; Denmark; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Mercaptopurine; Mesalamine; Population Surveillance; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Sulfasalazine | 2007 |
Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Male; Mesalamine; Middle Aged; Pericarditis; Recurrence; Sulfasalazine | 2007 |
Effect of sulphasalazine and balsalazide on histamine release from mast cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Gastrointestinal Agents; Histamine Release; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Mast Cells; Mesalamine; Oxidants; Phenylhydrazines; Rats; Sulfasalazine | 2007 |
Ulcerative colitis: responding to the challenges.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Immunologic Factors; Infliximab; Male; Mesalamine; Recurrence; Sulfasalazine; Treatment Outcome | 2007 |
[A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Colonoscopy; Female; Humans; Mesalamine; Pancreatitis; Sulfasalazine; Tomography, X-Ray Computed; Young Adult | 2008 |
Renal effects of long-term treatment with 5-aminosalicylic acid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Creatinine; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Mesalamine; Middle Aged; Nephritis, Interstitial; Retrospective Studies; Sulfasalazine; Time Factors; Young Adult | 2009 |
Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia.
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Mesalamine; PPAR gamma; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sulfasalazine; Tropomyosin | 2009 |
Medical therapy of IBD in 2009.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Natalizumab; Probiotics; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
Topics: Adult; Antigen-Presenting Cells; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cell Survival; Chronic Disease; Cytokines; Demography; Female; Humans; Inflammation Mediators; Interferon-gamma; Lymphocyte Activation; Lymphocytes; Male; Mesalamine; Middle Aged; Sulfasalazine; Tumor Necrosis Factor-alpha | 2010 |
Managing the risks of IBD therapy.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Risk Management; Sulfasalazine | 2009 |
Diaphragm disease and small bowel enteropathy due to nonsteroidal anti-inflammatory drugs: a surgical perspective.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Constriction, Pathologic; Diaphragm; Diclofenac; Female; Humans; Intestinal Diseases; Intestinal Mucosa; Intestinal Obstruction; Intestine, Small; Male; Mesalamine; Middle Aged; Sulfasalazine; Treatment Outcome | 2011 |
Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach.
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Patient Compliance; Pharmacoepidemiology; Portugal; Prevalence; Sex Factors; Sulfasalazine | 2010 |
High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.
Topics: Adolescent; Aminosalicylic Acids; Azathioprine; Biotransformation; Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphopenia; Male; Mesalamine; Purines; Salicylates; Sulfasalazine | 2010 |
Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Blastocystis hominis; Blastocystis Infections; China; Colitis, Ulcerative; Comorbidity; Feces; Female; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Sulfasalazine; Treatment Outcome | 2011 |
Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines.
Topics: Aspirin; Capsules; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Mass Spectrometry; Medication Systems; Mesalamine; Phenethylamines; Polypharmacy; Salicylates; Sulfasalazine; Tablets; Technology, Pharmaceutical; Time Factors | 2011 |
Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
Topics: Chromatography, Liquid; Dimenhydrinate; Drug Stability; Humans; Linear Models; Mesalamine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfapyridine; Sulfasalazine; Tandem Mass Spectrometry | 2011 |
A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopterins; Drug Evaluation, Preclinical; Enzyme Inhibitors; Mesalamine; Methods; Protein Binding; Saccharomyces cerevisiae; Sulfapyridine; Sulfasalazine; Two-Hybrid System Techniques | 2011 |
[Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Lung Diseases, Interstitial; Male; Mesalamine; Middle Aged; Pancreatitis; Sulfasalazine; Young Adult | 2011 |
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chi-Square Distribution; Cohort Studies; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hungary; Immunosuppressive Agents; Incidence; Infliximab; Logistic Models; Male; Mercaptopurine; Mesalamine; Methotrexate; Phenotype; Proportional Hazards Models; Retrospective Studies; Steroids; Sulfasalazine; Surveys and Questionnaires | 2012 |
[Guidelines for the management of ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Humans; Hydrocortisone; Infliximab; Injections, Intravenous; Mesalamine; Methylprednisolone; Severity of Illness Index; Sulfasalazine | 2012 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2012 |
Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Granulocytes; Humans; Kaplan-Meier Estimate; Leukapheresis; Longitudinal Studies; Male; Mesalamine; Monocytes; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Substance-Related Disorders; Sulfasalazine; Treatment Outcome | 2012 |
Comparison of the effect of mesalazine and sulfasalazine on laboratory parameters: a retrospective observational study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cohort Studies; Databases, Factual; Female; Gastroenteritis; Humans; Leukocyte Count; Leukopenia; Male; Mesalamine; Middle Aged; Platelet Count; Renal Insufficiency; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Thrombocytopenia; Young Adult | 2012 |
Clinical course of intestinal Behcet's disease during the first five years.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Disease Progression; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Mesalamine; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Sulfasalazine | 2013 |
Enzyme-responsive controlled release of covalently bound prodrug from functional mesoporous silica nanospheres.
Topics: Drug Carriers; Hydrogen-Ion Concentration; Mesalamine; Nanospheres; Oxidoreductases; Porosity; Prodrugs; Silicon Dioxide; Sulfapyridine; Sulfasalazine | 2012 |
[Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biological Factors; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Retrospective Studies; Sulfasalazine | 2013 |
5-ASA induced recurrent myopericarditis and cardiac tamponade in a patient with ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiac Tamponade; Colitis, Ulcerative; Female; Humans; Mesalamine; Pericarditis; Phenylhydrazines; Sulfasalazine; Young Adult | 2013 |
Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Component Removal; Child; Colitis, Ulcerative; Combined Modality Therapy; Female; Granulocytes; Humans; Male; Mesalamine; Monocytes; Prednisolone; Remission Induction; Severity of Illness Index; Sulfasalazine; Treatment Failure; Young Adult | 2013 |
Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach.
Topics: Aminosalicylic Acid; Animals; Azo Compounds; Colitis; Colon; Drug Design; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Models, Animal; Prodrugs; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2013 |
Persistence to oral 5-aminosalicylate therapy for inflammatory bowel disease in Australia.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Australia; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Patient Compliance; Prescriptions; Retrospective Studies; Sulfasalazine; Time Factors; Treatment Outcome | 2014 |
Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Diarrhea; Female; Humans; Hypersensitivity; Inflammation; Mesalamine; Severity of Illness Index; Sulfasalazine; Suppositories | 2014 |
Allicin alleviates inflammation of trinitrobenzenesulfonic acid-induced rats and suppresses P38 and JNK pathways in Caco-2 cells.
Topics: Animals; Caco-2 Cells; Disulfides; Humans; Inflammation; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Male; Mesalamine; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Sulfasalazine; Sulfinic Acids; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2015 |
Two-Stage Single-Compartment Models to Evaluate Dissolution in the Lower Intestine.
Topics: Biological Availability; Colon; Humans; Ileum; Mesalamine; Naphthyridines; Pharmaceutical Preparations; Solubility; Sulfasalazine; Therapeutic Equivalency | 2015 |
Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; China; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Female; Hospitalization; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Retrospective Studies; Sex Distribution; Steroids; Sulfasalazine; Young Adult | 2016 |
Mesalazine allergy in a boy with ulcerative colitis: clinical usefulness of mucosal biopsy criteria.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis, Ulcerative; Colon; Colonoscopy; Drug Hypersensitivity; Drug Substitution; Humans; Intestinal Mucosa; Male; Mesalamine; Sulfasalazine | 2016 |
Ozanimod Treatment for Ulcerative Colitis.
Topics: Colitis, Ulcerative; Humans; Mesalamine; Remission Induction; Sulfasalazine | 2016 |
Ozanimod Treatment for Ulcerative Colitis.
Topics: Colitis, Ulcerative; Humans; Mesalamine; Remission Induction; Sulfasalazine | 2016 |
Pediatric Pyoderma Gangrenosum: A Retrospective Review of Clinical Features, Etiologic Associations, and Treatment.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Mesalamine; Pyoderma Gangrenosum; Retrospective Studies; Sulfasalazine | 2017 |
Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Animals; Caprylates; Colitis; Colon; Dextran Sulfate; Drug Discovery; Drug Evaluation, Preclinical; Eicosapentaenoic Acid; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Mice; Mice, Inbred C57BL; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfasalazine | 2016 |
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult | 2017 |
Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Compounding; Female; Humans; Japan; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Recurrence; Severity of Illness Index; Sulfasalazine; Young Adult | 2017 |
Effects of salazosulfapyridine on the profile of cell surface proteins, revealed by biotinylation of cell surface proteins and 2-dimentional electrophoresis.
Topics: Biotinylation; Cell Line, Tumor; Humans; Membrane Proteins; Mesalamine; Sarcoma, Synovial; Sulfapyridine; Sulfasalazine; Two-Dimensional Difference Gel Electrophoresis | 2019 |
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition to Disease; Genome-Wide Association Study; Genomic Structural Variation; Haplotypes; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Japan; Leukopenia; Logistic Models; Mercaptopurine; Mesalamine; Pharmacogenetics; Pyrophosphatases; Retrospective Studies; Risk; ROC Curve; Sulfasalazine | 2018 |
Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide.
Topics: Colitis, Ulcerative; Comprehension; Disease Management; Drug Therapy, Combination; Female; Guidelines as Topic; Humans; Male; Mesalamine; Patient Education as Topic; Sulfasalazine; United States | 2019 |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Canada; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Methotrexate; Prednisolone; Societies, Medical; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2019 |
Hyposensitization trial using salazosulfapyridine in a case of mesalamine intolerance.
Topics: Abdominal Pain; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Humans; Male; Mesalamine; Middle Aged; Myalgia; Sulfasalazine | 2019 |
Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Topics: Adalimumab; Adolescent; Antirheumatic Agents; Behcet Syndrome; Child; Colchicine; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mesalamine; Prednisolone; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Symptom Assessment; Taiwan; Tertiary Care Centers; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experience.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Colitis, Ulcerative; Dosage Forms; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Italy; Logistic Models; Male; Mesalamine; Middle Aged; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2019 |
5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Chromatography, Liquid; Colitis; Colon; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Interleukin-10; Male; Mesalamine; Mice; NF-kappa B; Nicotinic Acids; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Sulfasalazine | 2020 |
[DRUG-INDUCED BILATERAL NEPHROLITHIASIS IN AN ULCERATIVE COLITIS PATIENT: A CASE REPORT].
Topics: Colitis, Ulcerative; Female; Humans; Lithotripsy; Mesalamine; Middle Aged; Nephrolithiasis; Sulfasalazine; Treatment Outcome | 2019 |
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.
Topics: Abdominal Pain; Administration, Oral; Adult; Colitis, Ulcerative; Diarrhea; Disease Progression; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Sulfasalazine; Time Factors | 2021 |
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
Topics: Adolescent; Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Comorbidity; COVID-19; Crohn Disease; Female; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; SARS-CoV-2; Sulfasalazine; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor Inhibitors | 2021 |
A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn's disease and ulcerative colitis.
Topics: Chromatography; Colitis, Ulcerative; Crohn Disease; Drug Combinations; Folic Acid; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 2020 |
COVID-19 in IBD: The experience of a single tertiary IBD center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Biological Products; Colitis, Ulcerative; COVID-19; Crohn Disease; Deprescriptions; Female; Gastrointestinal Agents; Hospitalization; Humans; Inflammatory Bowel Diseases; Italy; Male; Mesalamine; Middle Aged; SARS-CoV-2; Sulfasalazine; Tertiary Care Centers; Time-to-Treatment; Tumor Necrosis Factor Inhibitors; Young Adult | 2021 |
A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; COVID-19; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Machine Learning; Male; Mesalamine; Middle Aged; Sulfasalazine; United States; Young Adult | 2021 |
Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry.
Topics: Adrenal Cortex Hormones; COVID-19; Humans; Inflammatory Bowel Diseases; Mesalamine; Registries; SARS-CoV-2; Severity of Illness Index; Sulfasalazine; Tumor Necrosis Factor-alpha | 2022 |
Design of Clinical Trials for Mild to Moderate Ulcerative Colitis.
Topics: Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 2022 |
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Colitis, Ulcerative; Humans; Mesalamine; Neoplasm Recurrence, Local; Remission Induction; Sulfasalazine | 2022 |
A high adalimumab induction dosing regimen achieves clinical and endoscopic remission in super-refractory ulcerative colitis.
Topics: Adalimumab; Colitis, Ulcerative; Humans; Mesalamine; Remission Induction; Sulfasalazine; Treatment Outcome | 2022 |
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.
Topics: Colitis, Ulcerative; Humans; Mesalamine; Remission Induction; Sulfasalazine; Treatment Outcome | 2023 |
Selective detection of sulfasalazine antibiotic and its controllable photodegradation into 5-aminosalicylic acid by visible-light-responsive metal-organic framework.
Topics: Anti-Bacterial Agents; Ecosystem; Eosine Yellowish-(YS); Humans; Mesalamine; Metal-Organic Frameworks; Photolysis; Sulfasalazine | 2022 |
Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis.
Topics: Adolescent; Azathioprine; Child; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Retrospective Studies; Sulfasalazine; Treatment Outcome | 2023 |
[A case of ulcerative colitis with mesalazine intolerance complicated with agranulocytosis and septic shock during salazosulfapyridine administration].
Topics: Aged; Agranulocytosis; Colitis, Ulcerative; Female; Humans; Mesalamine; Shock, Septic; Sulfasalazine | 2023 |